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ABSTRACT

Significance/Background: Obstructive Sleep Apnea (OSA) is the most common
disturbance during sleep affecting 30% of the population. The occurrence of
moderate/severe OSA is 11.4% in men and 4.7% in women. OSA is caused by repetitive
partial or complete obstruction of the upper airway with apnea episodes. OSA is
prevalent in western society, yet is frequently undiagnosed due to lack of knowledge of
the disorder. This population presents a challenge during the peri-operative period due to
increased risk for several complications. Of particular interest to Nurse Anesthetists, are
respiratory complications that result in delayed emergence from anesthesia, delayed post
operative recovery, increased apneic episodes, hypoxemia, and death. Examining
duration of recovery periods between the two OSA groups will help determine if patients
with additional cofactors benefit from longer post-operative monitoring or modification
of anesthetic technique.
Methods: An observational correlation design to include a non-randomized convenience
sample of two groups. Comparisons were made between groups regarding cofactors,
complications and duration of postoperative recovery times. Patients having elective
abdominal surgery under general anesthesia were identified. OSA status was determined
based upon Sleep Studies, or STOP-BANG tool criteria. Medical, surgical, and
anesthesia data was reviewed. Total recovery times and pre-existing disease documented.
Multiple Logistic and Regression testing compared effects of cofactors on postoperative
recovery times. Chi square analysis evaluated relationship of individual cofactors with
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OSA and Non-OSA patients. T-test analysis compared demographic information. P score
of < .05 was considered significant.
Results: This study indicated significant correlation with higher number of cofactors
amongst patients diagnosed with OSA (p< 0.012). Increased incidence of higher ASA
classification in OSA diagnosed patients; (p< .017) extended PACU stay time in OSA
diagnosed patients; (p= 0.05) and unplanned admissions in OSA patients; (p=. 007).
Patients with OSA use higher number of prescribed medications compared to non-OSA
patients have a 3.36 greater chance of hypertension as an additional cofactor (p< .05) and
were 8.75 times more likely to experience airway difficulties or complications with
general anesthesia when compared to non-OSA patients (p< .05). Multiple logistic
regression testing demonstrated increased incidence for both airway difficulties (p= .003)
and Hypertension (p=. 054). Multiple linear regression results indicate one cofactor HTN
as a significant predictor for PACU stay time. (R2= .179, R2adj = .136, F (1))
Implications: Findings will lead to optimum monitoring, management; recovery measures
and anesthesia techniques that will prevent extended postoperative periods and reduce or
eliminate postoperative complications of OSA.

Key Words: Obstructive Sleep Apnea, Cofactors, STOP-BANG
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CHAPTER 1
Introduction

Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep
affecting 2-26% of the general population. (Chung et al, 2008) The occurrence of
moderate to severe OSA is estimated to be 11.4% in men and 4.7% in women. (Seet et al,
2010) OSA is a prevalent problem in Western Society estimated to occur between 1 to
9% in patients presenting for surgery, yet it is frequently undiagnosed due to lack of
awareness or knowledge of the disorder. (Kaw et al, 2006)
OSA is caused by repetitive partial or complete obstruction of the airway during
sleep. Diagnosis of OSA is determined by the occurrence of airway obstruction during
sleep with apnea periods lasting greater than 10 seconds for five or more times per hour
with a resultant decrease in arterial oxygen saturation (Sa02). (Seet et al, 2010) These
events are known as apnea/hypopnea episodes and the measurement of episodes is
referred to as the Apnea-Hypopnea Index [AHI]. The degree of severity of this disorder is
determined by the number of AHI's per hour (AHI: 5-15 mild, > 15-30 moderate, and >
30 severe).
A Polysomnography study otherwise known as a Sleep Study is recognized as the
"Gold Standard" for the diagnosis of OSA. Polysomnography data defines the degree of
severity of the condition by the number of apneic episodes. Unfortunately
polysomnography testing is time consuming; patients are reluctant to participate in them,
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they require an extended stay in the sleep lab; and are expensive. Medical professionals
have become more aware of OSA as a significant disorder with resulting adverse effects
for their patients. More physicians are consulting to polysomnography specialists for
sleep studies to ascertain occurrence and severity of OSA, and the availability of
appointments have become more limited. Unfortunately for the OSA patient scheduled
for surgery, polysomnography cannot be obtained rapidly and this may be the cause of
OSA going undetected. (Chung, 2008) Subsequently, the OSA patient population
presents a unique challenge during the peri-operative period due to an increased risk for
lack of identification and subsequent life threatening complications. Of particular interest
to the Nurse Anesthetist treating a OSA patient, are the respiratory complications that can
result in delayed emergence from anesthesia, delayed post operative recovery, increased
apneic episodes, hypoxemia, cardiac disturbances, and ultimate death.
Obesity, gender, snoring, and age are strong indicators in the occurrence for OSA.
Hypertension, cardiovascular disease, diabetes, and stroke are prevalently reported as
confounding and coexisting factors. (Dykes et al, 1996) Netzer at al. (2003) surveyed
OSA patients in 26 US primary care clinics and 14 European primary care clinics.
Comparison of the results indicated similar symptoms regardless of age, gender, and
hypertension. Obesity was common between both sets of OSA patients although the
incidence was much higher in the United States than in Europe. In a Spanish study,
Duran et al. (2001) reported linkages between OSA and hypertension after interviewing
over 2,000 patients.
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The predominant cardiovascular effects of OSA are hypertension and refractory
bradycardia followed by abrupt tachycardia. (Vanninen et al, 1996). The hemodynamic
instability seems to be related initially to hypoxemia from the airway obstruction, and
then sudden arousal as the patient awakens to breath. The rapid fluctuations of vasoactivity is thought to be responsible for the incidence of cardiac arrhythmias, the
development of chronic arterial hypertension, the occurrence of myocardial infarction,
and sudden cardiac death (Vanninen et al, 1996)
The severity and incidence of documented post surgical complications from patients
with moderate to severe OSA is significant. Yet, most of the data on incidence,
occurrence, surgical complications and treatment of the OSA patients come from case
reports and retrospective reviews not empirical studies. (Chung et al, 2008)
The American Society of Anesthesiologist (ASA) developed guidelines in 2006,
based on Level IV evidence and expert consensus reports to address the identification and
treatment needs of the OSA patient. The ASA consultants reached agreement on
treatment criteria for most simple outpatient and minor orthopedic surgical procedures
but could not find consensus regarding more invasive surgeries. The guidelines
emphasized that certain factors needed to be considered when determining both
preoperative and postoperative risk for the OSA patient: status of sleep apnea, (treated or
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are
they appropriately managed), type of surgery, and anesthesia modality.
(Chung et al, 2008) The key experts in the diagnosis and treatment of the OSA patients
acknowledge the poor quality of evidence. A citation from the American Academy of

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

8

Sleep Medicine stated that the scientific literature regarding perioperative risk and best
management techniques for OSA patients was scanty and of limited quantity, more
empirical studies are needed. (Meoli et al, 2003).

The ultimate goal for all Nurse

Anesthetists is to provide the safest, highest quality anesthetic management and care to
their patients. If Nurse Anesthetists can identify and understand the coexisting factors
creating the greatest risk for perioperative complications in the OSA patient, they can
better prepare themselves to manage those risks and provide optimum care. Nurse
Anesthetists can select anesthetic practices that minimize risk and maximize safer
outcomes. Development of more concise and accurate techniques to eliminate the factors
producing increased risk for this population could be incorporated. Valid criteria for
preoperative identification of the OSA patient could be developed and preoperative
management techniques could be identified. Established guidelines and protocols could
be created to decrease or eliminate most if not all risk factors. The complete elimination
of incidence and occurrence of morbidity and mortality for the OSA patient in the
perioperative environment would be the ultimate goal.
Purpose and Specific Aims

The purpose of this study is to identify preexisting factors that significantly impact
postoperative recovery times for patients undergoing surgical procedures.
Specific aims of this study include:
Aim 1. To examine the difference between the postoperative stay times of OSA and
Non- OSA patients.
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Aim 2. Compare OSA and Non OSA patients in regards to existing cofactors and
medical treatments
Aim 3. Assess the relationship between OSA and airway management difficulties and
complications
Aim 4. Assess the relationship between the pre-existing cofactors of: Hypertension,
Cardiovascular disease, diabetes and GERD.
Aim 5. Examine which of the pre-existing cofactors account for the explained
variance in postoperative recovery time.
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CHAPTER TWO
Literature Review

The purpose of this study is to identify preexisting factors that significantly impact
postoperative recovery times for Obstructive Sleep Apneic patients undergoing surgical
procedures. Obstructive sleep apnea (OSA) both diagnosed and undiagnosed is one pre
existing factor identified as increasing medical and surgical risks and ultimately increased
morbidity and mortality for individuals during the surgical, and perioperative
environment. Yagg and associates (2005) argue untreated OSA significantly and
independently increased the incidence of stroke or death from any other underlying
cause. Patients with undiagnosed OSA pose greater risk of airway compromise and
require additional measures and management regimes to ensure safe anesthesia care and
decreased PACU length of stay, information related to the existence of co-morbidities is
of great significance. The effects of OSA and coexisting disease in the perioperative
setting have not been fully explained. Does OSA have a significant impact on underlying
disease processes that lead to perioperative complications and increased length of PACU
stay? A review of the relevant literature was conducted to identify the current state of the
science on the effects of OSA and coexisting factors on perioperative care. In this chapter
the literature review is presented to include OSA, OSA and comorbidities, assessment of
OSA, and the impact on health outcomes. The theoretical framework " Startling Resistor
Theory" guiding the study will also be presented.

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

11

Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a disorder becoming much more prevalent within the
population of the United States and Europe. Obstructive sleep apnea is a disorder that
occurs during the normal sleep cycle of certain individuals and can be elicited during
surgery or medical procedures using sedation and general anesthesia. Obstructive sleep
apnea is caused by repetitive partial and complete obstruction of the upper airway by
relaxed pharyngeal muscle and tissues during normal sleep. It is also facilitated by
implementation of vaporized anesthetic agents during surgery and the introduction of
narcotics and analgesic medications for deep sedation (Chung et al, 2008).
The etiology of OSA is not completely understood but there is a general consensus that
the negative pressure created by the inspiratory muscles exceeds the capacity of the upper
airway dilator muscles to maintain airway patency, thus obstruction of the nasopharynx,
oropharynx, and laryngopharynx are obstructed (Chung et al, 2008). The tensor
palantine, genioglossus, and hyoid muscles contract to dilate and elevate the
nasopharynx, oropharynx, and laryngopharynx respectively. Action of the tensor palatine
is mainly tonic activity and this action decreases during sleep leading to upper airway
resistance. The action of the genioglossus is phasic with inspiration; contraction of this
muscle advances the tongue forward and is essential in keeping the tongue from blocking
the oropharynx. Genioglossus function also decreases with sleep and has been shown to
cease completely during rapid eye movement (REM) sleep. Studies have noted that OSA
patients may have a primary myopathy of their genioglossus muscle leading to complete
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loss of function at the onset of an apneic event and returning at the termination of
obstruction (Chung et al., 2008; White, 1995).
Patencies of these three collapsible regions of the pharynx are dependent on the
inspiratory function of the three-dilator muscles. The larger the negative inspiratory
pressure during respiration the stronger the force of pharyngeal contraction required from
these dilator muscles to maintain patency of the airway. Pressure sensitive airway
receptors are responsible for instigating the negative pressure reflex response. This is
elucidated by the fact that the implementation of anesthesia effectively abolishes this
reflex (White, 1995). Finally a group of three individual muscles grouped together as the
hyoid muscles are responsible for enlarging and opening the laryngopharynx by elevation
of the hypo- epiglottic ligament. The activities of these muscles are also phasic with
respiration. Neck positioning and facial abnormalities can greatly affect the function of
the hyoid muscles leading to narrowing of the laryngopharynx (Pierce et al, 1999; White,
1995) Function of pharyngeal muscles and airway patency are critical during sleep. More
specifically during REM sleep. Rem sleep is a very deep sleep and is characterized by a
general loss of muscle tone as which has been demonstrated by electromyelographic
imaging. It is during REM sleep that rhythmic activity of the upper airway muscles can
cease completely, and upper airway resistance increases maximally. It has been noted that
the most important region of collapse is within the lateral pharyngeal muscle walls. In the
OSA patient apnea occurs when complete closure of the lateral pharyngeal walls occur.
Gradations of weakness within the lateral pharyngeal walls during Non REM sleep
results in audible snoring. Fluttering of weakened pharyngeal walls causes it. In general
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the weaker the walls the louder the snoring and complete closure results in absence of
sound (Wilson et al., 1999). Obesity has been found to be a direct cause of OSA due to
increased fat deposition in the pharynx; which has been demonstrated by magnetic
resonance imaging, to decrease airway patency (Mortimer et al., 1998). Furthermore, the
fat deposition in OSA patients has been found to predominate in the lateral pharyngeal
walls. The volume of pharyngeal wall fat correlates directly with the severity of OSA
(Horner et al., 1989;Shelton et al., 1993). The deposition of fat not only narrows the
airway in the OSA patient but it also changes the shape transforming the normal
elongated lateral wall with an elliptical shape to a more anterior posterior axis with a
rounded lateral wall and circular shape (Pierce et al., 1999). Studies denote that anteriorposterior axis leads to less efficient function of the pharyngeal airway dilator muscles
than an elongated elliptical axis (Leiter, 1996).

Overall patency of the pharyngeal airway is determined by varying pressure exerted on
the walls of the airway. The nasopharynx, oropharynx and laryngopharynx act like
compressible tubes and both internal and external wall pressures affect the opening of
such tubes. Transmural airway pressure is the difference between external and internal
airway wall pressures. If this pressure is equal and constant then the airway remains open
as long as the tissues remain compressible. In the obese patient external wall pressure are
increased due to the increased fat deposits within the submandibular tissue. OSA patients
typically present with short fat necks and "sagging jowl's". Davies et al, 1990-1992)
found significant correlation with increased neck circumference and severity of OSA.
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John L. Benumof (2002) defines obstructive sleep apnea as "cessation of airflow for more
than 10 seconds despite continuing ventilatory effort five or more times per hour of sleep
which is usually associated with a decrease in oxygen saturation of more than 4 percent"
(p.790) A series of respiratory events occur during an obstructive apnea episode. As the
duration of apnea increases pulmonary arterial oxygen tension (Pa02) decreases. Decreased
Pa02 that in turn augments carotid body output causing vasoconstriction and increased heart
rate causes arousal.
Concurrently, pulmonary artery carbon dioxide tension (PaC02) increases, which
stimulates central nervous receptors similarly eliciting arousal state. Ventilatory effort is
promoted due to the fluctuations of Pa02 and PaC02 and intra-airway pressures become
increasingly negative, increasing likelihood of airway closure. In this instance arousal
may be initiated by pressure sensitive receptors in the upper airway (Benumof, 2002).
The four mechanisms discussed lead to increased neural activity in the reticular activating
system and arouse the individual. Snoring, sputtering, gasping, twitching or extremity
movement may preclude the manner of arousal. The muscles of the pharyngeal airway
open in response to the arousal and ventilation reoccurs (Benumof, 2002, p.796).
The physiological events necessary for adequate ventilation are essential for the OSA
patient to support life. The repetitive recurrence of these essential physiological processes
have been found to adversely influence and enhance the occurrence of other disease
disorders such as hypertension, cardiac arrhythmia, myocardial infarction, diabetes, and
coronary vascular incidents (Chung et al., 2008). According to Seet et al. (2010)
Obstructive sleep apnea has been associated with several co-morbidities cardiovascular
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disease, including MI, heart failure, arrhythmias, hypertension, cerebrovascular disease,
metabolic syndrome, obesity, and gastroesophageal reflux. (P.200)
The occurrence of diagnosed obstructive sleep apnea patients has been estimated to be
1 in 4 men (11.4%) and 1 in 10 women (4.7%). The statistics are even greater in the
obese population; 7 of 10 obese individuals have been diagnosed with obstructive sleep
apnea. Due to the increase of obesity within our nation, it is estimated that within the
American population today a significant number of individuals; as many as 90%, may be
undiagnosed with obstructive sleep apnea. (Benumof, 2002; Chung et al, 2008; Seet et al,
2010) The presumption is the numbers will only increase, as the incidence of obesity
remains unchanged and in fact growing statistically. It is estimated that the number of
diagnosed and clinically presumptive sleep apnea patients will increase five to ten times
by 2012 and continue to escalate thereafter. (Benumof, 2002)
The implications for both a diagnosed and undiagnosed obstructive sleep apneic
population of such vast numbers is increased medical and surgical risks and ultimately
increased morbidity and mortality for these individuals during medical, surgical and
perioperative management. Untreated obstructive sleep apnea significantly and
independently increased the incidence of stroke or death from any other underlying
cause. (Yaggi et al, 2003p. 2040)
For Nurse Anesthetists and anesthesiologists; patients with undiagnosed obstructive sleep
apnea pose greater risk of airway compromise and require additional measures and
management regimes to ensure safe anesthesia care.
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Obstructive sleep apneic patients have statistically difficult airways for intubation,
increased sensitivity to anesthetic agents and a propensity for increased postoperative
adverse events and complications. (Seet et al., 2010)
Recent studies have demonstrated that patients with obstructive sleep apnea
undergoing upper airway surgery, joint replacement surgery and cardiac surgery exhibit
increased risk of postoperative complications. (Gupta et al, 2001; Kim et al., 2005; Liao
et al., 2009; Pang et al., 2006)
These findings are alarming and do not even represent the number of surgical or sedation
patients who may arrive for anesthesia with undiagnosed obstructive sleep apnea. It is
important that the OSA patient be preoperatively identified so that the anesthesia provider
may provide the necessary treatment precautions to eliminate operative and postoperative
complications and adverse events.
The established gold standard for diagnosing obstructive sleep apnea is
Polysomnography more commonly known as a sleep study. The purpose of
polysomnography is not only to establish a diagnosis of OSA but also to determine the
degree of severity of the obstructive airway disorder. The apnea hypopnea index (AHI)
is the number of adverse respiratory events occurring per hour of sleep. The American
Academy of Sleep medicine defines for mild OSA as 5- 10 AHI, moderate OSA as 15-30
AHI and severe OSA as more than 30 AHI within one hour of sleep. Differing
classification for OSA prevail for example the United States Medicare guidelines define
OSA as an AHI of 15, or an AHI of 5 with 2 comorbidities and in Canada the accepted
criteria is establishment of daytime sleepiness, without other definitive cause, or two
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other symptoms of OSA. (i.e. choking/gasping during sleep, recurrent awakenings from
sleep, daytime fatigue, impaired concentration) Duration of oxygen desaturation, rate of
desaturation, adequacy of ventilator recovery, and level of arousal are other factors that
have been incorporated to evaluate OSA. (Seet et al., 2006) (p.200)
Even with the accepted gold standard of diagnosis "polysomnography" there exist
problems with implementation of the test as well as accurate and consistent diagnosis of
the degree of severity of this disorder. Polysomnography is time consuming (8 hour to 2
consecutive night study), expensive, resource intensive, and not at all suitable as a short
term screening device. (Chung et al, 2007)
Eastwood et al (2010) cite an example of various studies in which the categorizing of
AHI of 5 within a 1993 Wisconsin Study in the New England Journal of Medicine was
the equivalent to a Chicago definition of a category AHI of 15. The absence of a global
consensus of standardized criteria for the definition of the severity of OSA has significant
impact on identification and comparative findings for research and methodologies. Lack
of standardization has significant effects on OSA prevalence estimates, treatment
decisions and the establishment of links between OSA and comorbidities. (Eastwood et
al, 2010)
In 2006, the American Society of Anesthesiologist attempted to provide consensus for
the diagnosis of OSA as well as provide management guidance. A task force made up of
a panel of 12 members including anesthesiologists, a bariatric surgeon, an
otolaryngologist and two methodologists developed "Practice guidelines for the
perioperative management of patients with obstructive sleep apnea". (Para. 3) The
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purpose of this publication was to aid in the identification of the OSA patient within the
preoperative interview and provide guidelines for perioperative management of their
care. The establishment of these guidelines resulted in a format of fourteen categorized
questions comprising a checklist of physical characteristics, identification of airway
obstruction during sleep, and complaints of somnolence. All criteria established to be
present and contributing to obstructive sleep apnea. The sensitivity of the task force's
checklist was 79% to 87% as compared to the "gold standard" of Polysomnography.
(Seet et al, 2010) Subsequently a more efficient, concise screening tool was developed
called the STOP-BANG questionnaire. A meta-analysis of clinical screening measures
for obstructive sleep apnea identified and evaluated 26 different clinical prediction tests,
8 of these were survey questionnaires, and 18 algorithms, regression models or neural
networks. The findings supported and recommended the STOP-BANG as a preoperative
screening tool on the basis of ease of use and the excellence of predictability of severe
OSA (AHI>30) with 96% sensitivity. The simple acronym STOP BANG and linear scale
make the tool practical and very user friendly in the perioperative setting (Ramachandran
et al., 2009).
Additional information related to the existence of comorbidities is of great significance
to the anesthesia provider. It is well established that untreated OSA results in greater
morbidity and mortality in the perioperative period. (Bahammam et al., 1999; Bixler et
al., 2000; Dykes et al., 1996; He et al., 1988;Hunge et al., 1990). Yet, the effects of OSA
and coexisting disease in the perioperative setting have not been fully explained. Does
OSA have a significant impact on underlying disease processes that lead to perioperative
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complications? Several studies have drawn associations between patients with OSA,
diabetes, cardiovascular disease, obesity, arrhythmias and stroke.

Obstructive Sleep Apnea and Diabetes
A high association between OSA and metabolic disorders would seem very likely since
the link with severe OSA and obesity as a risk factor are so strong. There is growing
evidence that OSA serves as an independent entity of risk for adverse glucose
metabolism. Does OSA have a definitive role in the onset of diabetes? The mutual
connections between obstructive sleep apnea and diabetes are still not fully understood. It
is known that the glucose sensing process uses the same neurotransmitter pathways as the
hypoxic sensing process. The carotid body glomus is the polymodel receptor that detects
low blood glucose. Rasche et al. (2010) identified that the hypoxic events associated
with obstructive sleep apnea combined with diabetes all signal responsive elements in the
carotid body. This carotid gluco-sensor malfunction could be challenged and unable to
initiate the regulatory process necessary to counter increased blood glucose. In this
manner sleep apnea may increase the propensity for the development of diabetes,
independent of other metabolic related processes. (Rasche et al, 2010)
Chasens (2003) examined some of the theories that might explain the relationship of
OSA and diabetes. Of definitive agreement among the theories is the centroid pattern of
obesity occurring in persons with insulin resistant or diabetes Type 2. The existence of
extra body weight increases the resistance on respiratory structures and leads to
narrowing and collapse of upper airway tissue in OSA. Yet Stahl (2002) offered a
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coexisting theory, that the hypoxia and hypercapnea that occur in OSA provoke
sympathetic nervous system stimulation that results in hyperinsulinemia. The mechanism
proposed for increased insulin resistance and glucose regulatory dysfunction is the result
of repetitive hypoxia and hypercapnea, which occurs with apneic events, triggers the
stress response invoking chemoreceptors in carotid bodies, aortic arch and in the medulla
of the brain.
The results of these processes are the release of catecholamines: epinephrine,
norepinephrine and Cortisol. OSA interferes with glucose management by insulin
deregulation (Chasens et al., 2003) (p.89). A study by Mahmood et al. (2009) also
supports the sympathetic response theory citing "severe OSA results from increased
neurogenic sympathetic activity and circulating levels of norepinephrine" which
predisposes to increased glycogenolysis, lipolysis, and insulin resistance. (P.219)
Another study by Eastwood et al. (2010) described obesity (excess adipose tissue) as
a" cofounder or active partner in crime" when evaluating the impact of OSA on
metabolic disorders (p. 590). If this were fact then you would expect that a relationship
with OSA and the development or existence of diabetes would depend on the amount of
adipose or fat cells the individual with OSA exhibits. Normal or lean BMI OSA
individuals would be unlikely to have diabetes. Speculation would seem to favor the fact
that body fat would be the greater modulator of diabetes rather than OSA since body fat
has direct impact on cause of diabetes. Yet, published studies suggest that OSA may
impair insulin secretion, leading to glucose intolerance or diabetes. This physiological
manifestation of an insulin- resistant state has little to do with obesity. Ultimately the
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"lean" OSA individual may still suffer from diabetes. (Ip et al, 2002; Punjabi et al, 2009)
Steiropoulos and colleagues (2009) conducted a study of 31-year-old males newly
diagnosed with OSA without diabetes and found significant correlations between
glycolated hemoglobin levels and AHI as well as arousal index and percentage of sleep
time with hemoglobin saturation less than 90%. The correlations suggest that OSA posed
a significant risk factor for glucose dysmetabolism irrespective of the presence of
diabetes. The authors suggest the need for addressing preexistence of OSA in both
diabetic and non-diabetic patients to effectively assess glycemic control. Additional
studies have shown strong associations between OSA, glucose intolerance, insulin
resistance and diabetes independent of obesity. A 2010 study by Arhonson indicated a
high prevalence of OSA in patients with diabetes Type-2. The existence of a graded and
inverse relationship between OSA severity and glucose control was demonstrated in
patients with Type 2 diabetes, after controlling for the degree of obesity (BMI), age, and
gender. Furthermore the study may have significant implications to support a hypothesis
that reducing the severity of OSA may improve overall glycemic control in diabetes Type
2 patients and prevent onset for the non-diabetic OSA patient.
A pilot study completed at Grenoble University in France consented 40 subjects with
Type 1 diabetes to be screened for obstructive sleep apnea. Sixteen of the 40 subjects
were determined by Polysomnography to have OSA. In addition, 10 of the 16 subjects
were classified with severe OSA. A total of 40% of the Type 1 diabetic subjects were
determined to have obstructive sleep apnea; this is an exceptionally high percentage. The
subjects were all of normal body habitus, not obese and BMI was not associated with
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pathological oximetry values. The pilot studies suggest a linkage between pharyngeal
neuropathy and high prevalence of OSA in Type 1 diabetic subjects. In a similar study
Ficker et al. 1998 demonstrated that obstructive sleep apnea was associated with
autonomic neuropathy in Type 2 diabetics (Borel et al, 2010).
In a United Kingdom a sample of 938 subjects with diabetes were recruited from a
tertiary hospital clinic and five primary care clinics within the community. Sleep studies
were obtained and prevalence of OSA was found in 23% of the respondents as compared
to 6% of the non-diabetics within that general community (Foster et al., 2009). A
Canadian study of 2,149 subjects; 8.1% were diagnosed with diabetes and a twofold risk
of OSA was found in the diabetes group when compared to the non-diabetic group,
despite adjustment for potential confounders (Ronskley et al., 2009). Elmasry (2001)
conducted a longitudinal study in Sweden looking at the relationship of diabetes,
hypertension and OSA. One hundred sixteen hypertensive subjects with OSA were
selected. They found that although obesity is strongly associated with the coexistence of
diabetes mellitus, severe OSA seems to add significantly to this association, Their
comparative study included 4 groups of hypertensive men (Non-OSA: non-obese, NonOSA: obese, OSA: non-obese and OSA: obese) the highest percentages of diabetes
occurred in the subjects with OSA: Obese. But of significance to the authors, 35% the
second highest incidence of diabetes was in the OSA: non-obese group. Elmasry et al.
conclude that following linear regression their data supported significant association
between AHI and fasting blood glucose, fasting serum insulin, and HbAlc levels. Using
multiple regression desaturation index also demonstrated significant association with
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fasting serum insulin, fasting blood glucose and glycohemoglobin -HbAlc. (p. 158) This
data supports the evidence that obstructive sleep apnea has independent and significant
adverse effects on fasting serum insulin, blood glucose and HbAlc when adjustments are
made for central obesity, even in normoglycemic hypertensive males (Elmasry et al.,
2001)

Associations of OSA and glucose disorders are not limited to western culture alone. In
a 2009 Japanese longitudinal study; subjects with nocturnal intermittent hypoxia
exhibiting AHI <5 and lowest Sp02 during the night were associated with an increased
risk of type 2 diabetes independent of the traditional risk factors of age, gender and BMI
(Muraki et al., 2010). Another study conducted in Japan 2010 examined the prevalence
of OSA associated with Type 2 diabetes. Of the 165 subjects that underwent
Polysomnography 89 were found to have clinically diagnosed OSA. The prevalence of
associative OSA and Diabetes in the Asian population was 53.9%, with 18% having
severe OSA and 15% classified as moderate OSA. In Japanese, 40 to 60 years old, the
study denotes a threefold increase in men (32% vs. 10%) and a twofold increase in
women (14% vs. 6%) with associative OSA and diabetes as compared to the general
population. The actual numbers of OSA and diabetes occurrence are more representative
of findings in the United Kingdom and Canada (Lam et al., 2010).
When examining the incidence of OSA and diabetes within different ethnic and age
subgroups it was determined that Hispanics had a high prevalence of Type 2 diabetes. It
was also observed that the occurrence of Type 2 diabetes in middle-aged subjects with
OSA was 2.8 times higher than in younger or middle aged subjects without OSA. Older
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subjects had higher odds of Type 2 diabetes regardless of OSA status. This may allude to
a genotype component responsible for diabetes disorders regardless of OSA (Mahmood
et al., 2009).
The Center of Disease Control estimates the number of individuals in the United States
with diagnosed and undiagnosed diabetes to be around 24 million. The prevalence of
diagnosed obstructive sleep apnea in patients with Type 2 diabetes ranges from 73 to 86
percent, this suggest a staggering number of individuals; approximately 17 million people
with diabetes are unaware of a significant co-morbidity. This is a major concern for
those in the medical profession, and more specifically for the anesthesia provider whose
delivery and management of care is directly influenced by the associated effects of
obstructive sleep apnea and diabetes. (Pamidi et al, 2010)

Obstructive Sleep Apnea and Cardiovascular Disease
A growing body of evidence supports obstructive sleep apnea as an important risk
factor for hypertension related cardiovascular disease and dysrhythmias. Lavie and
associates (2001) estimated that approximately 40 to 60 percent of individuals diagnosed
A

with obstructive sleep apnea in sleep labs had concurrent hypertension. This rate of
hypertension was two to three times greater than the general population. Since OSA
prevalence has increased to an estimated 34% (diagnosed and undiagnosed) of the
population in the last ten years; the increase in hypertension will also have grown
exponentially.
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A number of studies have elicited theories describing the physiological processes for
OSA's contribution to hypertension and arrhythmia disorders. Ryan et al (2009) suggest
that inflammatory processes leading to endothelial disturbances play an essential role in
the pathogenesis. The repetitive hypoxia -hypopnea events that occur in OSA create
short cycles of desaturation followed by rapid re-oxygenation, initiates the inflammatory
process. This intermittent re-oxygenation resembles the same characteristics of
reperfusion injury and is proposed to result in the development of atherosclerosis.
The inflammatory markers known as cytokines and chemokine's (adhesion molecules)
are precursors in the pathogenesis of atherosclerosis and are potential cardiovascular risk
markers. These inflammatory markers have been identified as independent risk factors
for cardiovascular diseases (Ryan et al., 2009). The cytokine Tumor Necrosis Factor
Alpha (TNF-a) is recognized as important in the development of atherosclerosis.
Circulating levels of TNF- a have been indicators for early signs of atherosclerosis in
middle aged men and are predictive for coronary heart disease and congestive heart
failure. Studies examining levels of TNF-a with obstructive sleep apnea syndrome have
consistently shown elevated levels of the cytokine in OSA subjects in comparison to
controls and independent of obesity. These same studies have demonstrated significant
reduction in TNF-a following implementation of continuous positive airway pressure
(CPAP) therapy. So, TNF-a levels could be the best predictors of cardiovascular risk for
the individual with obstructive sleep apnea (Ryan et al., 2009).
Another chemokine, Interleukin- 8 (IL-8) has been found to be associated with OSA.
IL-8 is another precursor to atherosclerosis; it plays a major role in plaque destabilization
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and atherogenesis. IL-8 levels were notably increased with OSA and similar to TNF-a
response; IL-8 levels demonstrated a significant reduction when CPAP treatment was
initiated within the study. Both the cytokine TNF-a and the chemokine IL-8 are
modulated by the same transcription factor Nuclear Factor Kappa B (NF-k B). This
transcription factor plays a predominate role in initiating the inflammatory process and its
effect on the other mediators supports the role of OSA in inflammatory response and
cardiovascular disturbances (Ryan et al., 2009). Yamauchi et al (2008) identified similar
processes as the Ryan study and cite the contribution of the inflammatory process and
immune response to the development of atherosclerosis.

Atherosclerosis is identified

as the "common pathological factor for cardiovascular disease" (p.756) This study
similarly identifies the hypoxia-re-oxygenation as the component of OSA causing the
inflammatory process. The study also demonstrated that OSA induced intermittent
hypoxia activated NF-k B and that this activated transcription factor induced the
inflammatory responses in the arterial walls that impairs endothelial function leading to
cardiovascular consequences. The re-oxidation and reperfusion phase results in the
production of reactive oxygen species (ROS). ROS reactive molecules damage intimal
cells and promote oxidative stress. A number of studies have reported markers of ROS
are associated with OSA. These two articles found similar conclusions: inflammatory
response and endothelial dysfunction lead to the pathogenesis of atherosclerosis.
Transcription factors, chemical mediators: cytokines, chemokines, markers of oxidative
stress are likely activated by OSA - related oxidative stress (hypoxia-reperfusion) and
may define the pathway in the cardiovascular consequences of OSA (Yamauchi et al.,
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2008). The first direct evidence at the cellular and molecular level, of the impact of
oxidative stress on the endothelial cells was determined by Padelletti et al (2008). They
found that the endothelial nitric oxide synthase (eNOS) and its phosphorylated active
form (p-eNOS) were weakened in the OSA patient and that the oxidative stress marker
nitrotyrosine, which is an indicator of nitric oxide inactivation by oxidative stress, was
elevated, (p. 3469)
Mansfield and Naughton (2005) described evidence of OSA's causation and progression
of congestive heart failure and cardiovascular disease including hypertension. Cardiac
preload and afterload are affected by intra-thoracic pressure. The fluctuations of
intrathoracic pressure (exaggerated falls of intrathoracic pressure) created by repetitive
ventilator efforts against closed airway occurring during the hypoxic- re-oxygenation
episodes of OSA create conditions of increased left ventricular afterload and decreased
preload. The result is overall reduction in stroke volume and cardiac output which over
time progresses to congestive heart failure (CHF) (Mansfield et al., 2005). Kato et al
(2000) and Gami et al (2005) studies found a relationship between OSA syndrome,
sudden death, and nocturnal myocardial infarction. Repetitive cycles of bradycardia and
tachycardia are commonly documented during sleep studies of the OSA patient. Severe
sinus bradyarrythmias are prevalent in OSA patients with severe hypoxemia, especially in
rapid eye movement (REM) sleep. Severe hypoxemia during REM sleep may predispose
OSA patients to abnormal heart rhythms such as extreme bradycardia, sinus pauses, or
conduction blocks. Evidence from previous studies also supports an independent
association of OSA and atrial fibrillation (Lavie et al., 2008).
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The effects of hypoxia, hypercapnea, baroreceptor desensitization, and arousal
responses are all factors that contribute to both the acute and chronic augmentation of the
sympathetic nervous system. Sympathetic nervous system activation remains the most
likely and consistently identified explanation for the development of chronic
hypertension (Mansfield et al., 2005). It has been demonstrated that patients with OSA
do not exhibit the normal nocturnal "dipping" of blood pressure during sleep. Nondipping nocturnal blood pressure remains a characteristic factor in underlying OSA
distinct from the hypertensive population without OSA, which may prove valuable as a
diagnostic measure (Portaluppi et al., 1997).
Various studies have encouraged the incorporation of CPAP to OSA patients as
restorative treatment for hypertension and CHF. Malone et al (date) found a 12%
improvement in left ventricular ejection fraction (LVEF) when CPAP via nasal cannula
was introduced for 4 weeks to their subjects diagnosed with idiopathic dilated
cardiomyopathy. In another study, 24 patients with CHF and OSA were randomized to
one month CPAP or no treatment groups. The CPAP treatment group demonstrated an
8.8% improvement in their left ventricular ejection fraction and a fall in mean systemic
blood pressure of 10mm hg was also reported. (Kaneko et al., 2003)
A controlled paralleled trial of 118 patients with hypertension and OSA underwent CPAP
treatment and mean systemic blood pressure fell by 2.5mmhg over 4 weeks. (Peperell et
al, 2002) The result was more pronounced in the more severe OSA group with
hypertension; mean systemic blood pressure dropped by 6.6mmhg. In these studies
CPAP appears to lower blood pressure and LVEF by eradicating obstructive sleep apnea-
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hypopnea. In a study of untreated hypertension in middle aged men with undiagnosed
mild OSA (AHI > 5) and without OSA the mean change in nocturnal blood pressure
during and after 3 weeks of nightly CPAP was significantly greater in the mild OSA
patients adjusted for age and BMI. The CPAP treatment did not affect the blood pressure
of non-apneic subjects (Marrone et al., 2003). The effectiveness of CPAP therapy in
improving cardiovascular disorders such as hypertension, and idiopathic cardiomyopathy
provides strong evidence that obstructive sleep apnea and its resultant hypoxic-hypopnea
events have a direct effect on cardiovascular function. The association of obstructive
sleep apnea events and endothelial dysfunction, oxidative stress, inflammatory pathways,
and sympathetic nervous system response warrants direct concerns for physicians and
anesthesia providers alike. The high prevalence of OSA and its close association with
cardiovascular dysfunctions lead too much greater risk for morbidity and mortality.
Adverse outcomes will definitely result if these associative disorders are not identified,
addressed, and corrected.

Post-operative Complications with OSA
The risk of serious postoperative complications has been previously addressed in
regards to obstructive sleep apnea alone. Most OSA patients have sleep disorders
involving both REM and Non REM sleep. Nocturnal apneic events coupled with
preoperative anxiety; common prior to surgery, leads to overall poor sleep quality, and
sleep deprivation prior to surgical events. This causes many patients to experience post
operative REM rebound characterized by increased episodes of airway atony and
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subsequently airway collapse. This phenomenon can occur up to the third or fourth
postoperative day when patients have returned home (Pang, 2006). Benumof (2004)
found supporting evidence that in the postoperative setting, sleep mechanics were
disturbed due to the requirement for increased analgesia for surgical pain. Analgesia
through the first three days after surgery tended to incur a life threatening apnea from
drug-induced sleep. He also described rebounds in REM sleep originating from poor
quality sleep this was believed to increase the danger of a detrimental natural deep sleepinduced apnea. He suggested that patients with OSA are at risk of prolonged apnea
during sleep for up to one week in the postoperative period.
Correlations between hypoxic events and episodes of recurrent oxygen desaturations
associated with adverse outcomes have been reported. Gupta et al (2001) examined
procedure specific complications in the post operative period and found that OSA
patients experience significantly more occurrence of complications than the group
without OSA. Complications included acute hypercapnea, PaCo2 >45, episodic
desaturations reflected by Sp02 <90% with witnessed apneic events; arrhythmias, MI, or
infarction, and delirium.
In the United Kingdom a mailed survey was provided to a group of anesthetists to define
perioperative care of adults with OSA: Perioperative complications included 34%
difficult intubations, 47% difficult ventilations, 24% cardiovascular instability, difficult
analgesia in 41%, difficult extubation 13%, postoperative apnea 46%, required
reintubation 27%, unplanned ICU admission 23%, and acute cardiac events
25%(Bamgbade et al., 2009).
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These findings support the need for accurately assessing the postoperative status of
OSA patients and determining criteria for risk assessment. Studies have shown strong
relationships between the numbers of oxygen desaturations episodes within the post
anesthesia care unit to occurrence of adverse events. Questions could be posed regarding
the causes of the postoperative complications. OSA attributed events such as: Hypoxia,
Hypopnea, Hypercapnea, snoring etc. Are they independently caused by the OSA
disorder? Or is their synergistic component with other cofactors (HTN, Diabetes, CVD)
that creates the adverse events? Does the OSA patient with one or more cofactors have
more adverse events and do they require a longer PACU stay?

There currently is no clear explanation. It would be valuable information for the
anesthesia provider and other health care providers to know the most significant cause of
adverse events in the OSA patient.

Preoperative assessment of all surgical patients using validated instruments would aid
in the identification of those patients with both known OSA and more importantly
identify those that are unknown. Cofactors can be identified and appropriate optimization
measured can be applied. Intraoperative management could be streamlined and specified
for the OSA patient in a manner that minimizes complications. Postoperative measures
and protocols could be developed to improve the care for the OSA patient; eliminating
the risk factors and provision for safe analgesia that inhibits heavy sedation while
promoting optimum oxygenation.
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Theoretical Framework
An English physiologist Ernest Starling identified a theoretical phenomenon of vessel
capacitance as influenced by flow, forces, and pressure. The Starling Resistor Theory
(Stalford, 2004) explains the function of fluid flow through the coronary arteries. The
Starling Resistor Theory is offered as a theoretical framework to compare and contrast
airway physiology and function within the normal adult airway and in the OSA airway.
The Starling Resistor Model (Stalford, 2004) can be readily applied to describe flow in
the upper airways. The concept provides an excellent explanation of airway dynamics as
influenced by changing forces or pressures. A resistor is described as a collapsible tube
passing through a chamber that is capable of having it's pressure changed. For
application purposes we can identify the oropharynx as the tube and the surrounding
tissue of the neck as the chamber. If the oropharynx remains open then airflow will be
determined by the pressure differences from the two sides of tissue within the neck; from
the pressure above; the proximal region of the nose or mouth and from the pressure
below; the distal portion of the trachea.
The main characteristic dysfunction of OSA is obstruction of airflow. The patient with
OSA has recurrent apneic events that are the result of a closed or "blocked" airway that
occurs during sleep. To understand the co-existing factors that may contribute to the
adverse affects of OSA we must first understand the anatomic and physiologic process
that defines OSA. The airway of the OSA patient presents differently than that of a
typical adult airway. An OSA patient's airway is smaller and narrower in contrast. The
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OSA airway has a more lateral axis while the typical adult airway is more horizontal.
This variant is thought to be caused by an excess of redundant tissue. In fact a definitive
feature of OSA patients is an increased neck circumference or "thick neck" (Benumof,
2004). When sleeping the oropharyngeal muscles of the adult airway are relaxed and
pharyngeal narrowing occurs and there is increased negative inspiratory pressure
especially during rapid eye movement (REM) sleep. Additional negative inspiratory
pressure is generated by diaphragmatic excursion and pharyngeal dilator muscle activity
is incorporated as a compensatory mechanism, which maintains airway patency in the
normal adult. In the OSA patient, pharyngeal dilator muscle activity maintains patent
during awake periods but the muscle activity is lost when the OSA patient is asleep.
Excessive adipose tissue in the neck of the OSA patient surrounds the oropharynx and
compresses the airway making muscular activity less effective. Increased negative
inspiratory pressure along with snoring, which can cause vibratory trauma can further
enhance upper airway narrowing (Woodson et al., 1991).
The tissue pressure (Ptissue) corresponds directly to the pressure surrounding the tissues
of the oropharynx that constrict the upper airway. A high opening pressure (Pproximal)
will assist in overcoming the collapsing pressure of tissue (Ptissue). A low or negative
pressure below the vocal cords (Pdistal) that occurs as a result of the inspiratory effort
will contribute to airway collapse if Ptissue is elevated. When sufficient muscular tone is
operative in tissues surrounding the collapsible tube, the effect is a "lifting of the tissue
"away from the collapsible portion. Thus Ptissue does not contribute to airway
collapse. (Stalford, 2004)

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

Figure 1. Starling Resistor Model
Pd (distal)=upstream pressure, Pp (proximal)=downstream pressure and Pt
(tissue)=pressure in the chamber (Stalford, 2004).
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In the OSA patient, arousal is essential for airway patency and survival. A lack of
oxygenation leads to hypoxemia and hypercarbia. Increased levels of C02 stimulate
chemoreceptors within the CNS, which in turn release neurotransmitters promoting
arousal. Reflex response activates pharyngeal dilator muscles and airways open,
ventilation is returned. (Kaw et al, 2006)
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Starlings Resistor Theory was formulated to explain the properties of vascular
compliance and resistance forces. The theory has already been established and accepted
as defining the properties of fluid flow through blood vessels, and vascular circulation.
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Although the coexisting factors of hypertension and cardiac disturbances in the OSA
patient are not fully understood, an association with flow, increased pressure, and
collapsibility may offer an explanation using Starling's Resistor Theory (Stalford, 2004).
Applying this theoretical framework for both airway and hemodynamic pressures is
appropriate and could indicate symbiotic relationships
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CHAPTER 3
METHODOLOGY

The purpose of the study is to identify preexisting factors that significantly impact
postoperative recovery times for patients undergoing surgical procedures. The research is
informed by the Starling Resistor Theory (Stalford, 2004). The relationship and
associations of pre-existing disorders such as hypertension (HTN), diabetes (DM-II),
cardiovascular disease, and body mass index (BMI) in obstructive sleep apnea (OSA)
patients will be investigated as co-factors in PACU recovery times. Hypertension,
cardiovascular disease, and diabetes are prevalently reported as confounding and
coexisting factors in obstructive sleep apnea patients. (Dykes et al, 1996). Yet there is no
evidence as to whether these cofactors have any deleterious affect on post surgical
recovery times of sleep apnea patients. This chapter presents the research methodology
including design, sample and sampling, data collection procedures with instrumentation,
and data analytic procedures. The protection of human subjects is also discussed.

Design
A quantitative observation correlational design method will be utilized for the proposed
study. Determining a relationship of postoperative ambulatory care unit (PACU) stay
times between obstructive sleep apnea patients and those without sleep apnea following
elective abdominal surgery. The relationship and associations of pre-existing disorders
such as hypertension (HTN), diabetes (DM-II), cardiovascular disease and GERD in
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obstructive sleep apnea (OSA) patients will be investigated as co-factors in PACU
recovery times. Munro (2005) states correlational techniques are used to study relationships.
They may be used in exploratory studies, when the intent is to determine whether relationships
exist, or in hypothesis testing studies, in which we test a hypothesis about a particular
relationship, (p. 239)

Based upon a review of the literature the relationship between OSA and the cofactors
of hypertension, diabetes, and cardiovascular disease have been identified. Data findings
have reported each cofactor's independent relationship with OSA. It is beneficial to this
study to investigate the correlations of several cofactors and their relationship with OSA.
Additionally, to provide the body of evidence as to which cofactors more significantly
affect the occurrence, prevalence and adverse effects of OSA.

SAMPLE
A purposive sample of active duty, retired, or family members of military service
members who have consented to elective surgery at the Naval Medical Center San Diego
(NMCSD) and received a score of 5 or greater from preoperative evaluation using the
STOP-BANG screening measurement will provide data for the proposed study.
Inclusion Criteria consists of males and females 18 to 65 years, who have elected to
have general anesthesia, surgery, category ASA I - III, able to read and comprehend
English. Exclusion Criteria consisted of members above who had pre-existing pulmonary
disorders (COPD, etc.), neurological dysfunction, delayed or decreased cognitive
function and recent MI.
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SAMPLE SIZE CALCULATION
For the purpose of this study which is to determine if identified obstructive sleep
apnea (OSA) patients have longer PACU recovery times as compared with non-OSA
patients undergoing elective surgery and if their is an association between OSA patients
with pre-existing factors (HTN, Diabetes, Cardiovascular Disease, BMI, type of surgery)
and extended PACU recovery times. A multiple linear regression will be used to analyze
the data. There is no consensus on mechanisms determining samples; several
mathematical formulas exist along with computer program power analysis software to
help determine appropriate sample size. These formulas and software programs assure
that the number of participants selected for the study provide enough information to
establish a valid correlation of event and outcome. Computer programs give an adjusted
R2 (correlation) as well as an actual R2 (Munro, 2005) This type of computed formula is
referred to as a shrinkage formula because of the relationship between the predictive
values of actual vs. adjusted R2. Calculated math formulas vary, Cohen for example
establishes effect size; Nunnally and Bernstein 1994 suggest that 10 subjects per
predictor is a minimum "in order to even hope for a stable prediction equation" (p.201).
Published studies have cited occurrence of OSA in western populations within
the range of 23-38%. (Benumof, 2004 Seet et al 2010, Eastwood, 2010 Chung et al 2008)
More specific approximation of incidence of OSA in surgical patients falls within 2426%. (Chung et al, 2008) The sample size for this study will be based on the consensus of
data establishing a 26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and
Katz (2006) guidelines of ten subjects per predictor, 50 subjects with OSA would be a

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

40

minimum. Considering the incidence of OSA in the surgical population of 26% the
estimated sample size for this study is 100 subjects.

SETTING
Data collection for this research will take place in the preoperative clinic, main
operating room, and post-operative acute care unit of the Naval Medical Center San
Diego (NMCSD). NMCSD is the largest naval military medical center within Naval
Medicine West Region. The navy medical center averages 1,340 surgical cases a month,
performing a variety of surgical procedures for numerous specialty medical services. It
provides treatment and procedures for the largest number of military beneficiaries in the
Western United States.

MEASUREMENT
Obstructive Sleep Apnea is caused by physiological closure of the oropharyngeal
airway during sleep and will be assessed and defined by utilizing the STOP-BANG
screening parametric, a concise and simple to use screen specifically developed to assess
OSA criteria. Use of a previously established database evaluating OSA using the StopBang Measure will be incorporated. The database was generated in a phase one potion of
this cumulative research. Stop-Bang is an 8-question (item) assessment that has been
implemented and validated for use in defining OSA criteria in a surgical patient
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population (Chung, 2008). OSA is defined by a greater than 5 score determined from
responses to the 8 questions.
The STOP Bang Questionnaire is made up of 8 questions related to:
1). Snoring
2). Tiredness
3). Observed Apnea during sleep
4). High Blood Pressure.
5). BMI (Body Mass Index)
6). Age
7). Neck Circumference
8). Gender
It is a self- report, short answer /choice (yes/no) paper and pencil scale that takes an
estimated 1 minute to complete.

RELIABILITY AND VALIDITY
Factor Analysis was completed and 4 underlying factors emerged for the 14
questions related to snoring, tiredness, apnea and hypertension. Four questions were
chosen that best represented the factor criteria in the simplest report format. Validity was
determined via a pilot study comparing results from the STOP questionnaire to the
established OSA measurement of polysomnography (sleep study). The sensitivity of the
STOP questionnaire was 72%, the specificity was 33.3%, the positive predictive value
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75%, and the negative predictive value was 30%. Reliability was established via testretest. Fifty-five patients answered the STOP questionnaire twice during a time interval
of 1-27 days (median 8 days); 53 (96.4%) of the patients had the same score upon
retesting. It was also demonstrated that the positive predictive value greatly increased in
groups with: BMI > 35 kg/m2, age > 50 y/o, neck circumference > 40cm, and male
gender. Thus a STOP-BAG measurement has been adapted for even greater reliability
that includes B- BMI, A- age, N-neck circumference, and G-gender. (Chung, 2008)

ALDRETE SCORE

Protocols are utilized to immediately assess a patient's recovery from anesthesia
after surgery. PACU guidelines govern different phases of the anesthesia recovery
process these include early recovery, intermediate recovery, and late recovery. In Phase I,
following the anesthesia providers report, PACU nurses implement a scoring system or
scale to continue assessment of the patients. The Aldrete Score is a universally used
scale, which scores the patient on mobility, respiratory status, circulation, consciousness,
and pulse oximetry. The Aldrete score was formulated in 1970 and modified in 1992.
Aldrete uses a rating scale of 0 thru 2 to score the five physiological criteria previously
listed. A score of 2 in each category is considered best in all areas. The patient is
discharged from the PACU when he/she meets the established criteria. A patient must
attain an overall score of at least 9 to be considered for progression and discharge.
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DATA COLLECTION PROTOCOL

Patients scheduled for elective surgery are directed to the preoperative clinic to
complete a preoperative questionnaire. This questionnaire identifies patient having any
pre-existing disease factors such as hypertension, diabetes, suspected, or diagnosed
obstructive sleep apnea. These patients are flagged and required to have a more in depth
assessment by an anesthesia provider prior to their surgery, this could occur anytime
between 1 and 14 days prior to their elected procedure. The preoperative nursing staff
hand out the STOP- BANG measurement questionnaire along with the standard
preoperative questionnaire. The preoperative score the STOP-BANG tool; patients with a
score of 5 or greater will receive further assessment from an anesthesia provider. Any
other preexisting factors will be identified and assessed by the anesthesia provider at this
time.
Phase I. A computerized data query comprised of research study criteria was completed.
The primary investigator reviewed query results and compiled a purposive list of
participant medical records containing the required data criteria for the study. A
purposive sample of medical records was pulled and all data was obtained and recorded
by the primary investigator. Data management and security was maintained in
compliance with HIPAA standards and those of the Clinical Investigations Department
(CID) at NMCSD.
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Phase II. Data collection will consist of anesthesia assessment record review, Innovian
electronic anesthesia intra-op and post-op record review, essentris electronic record
documentation review from PACU and SDS environments. During record review
demographic data will be recorded to include age, gender, BMI. In addition PACU
recovery time, medications, existing cofactors, type and length of surgical procedure and
complications will be recorded. Aldrete and PADSS information and score will be
reviewed. STOP BANG measurement questionnaire reviewed and evaluated. CPAP use
determined. EKG's will be verified if subjects have HTN, cardiovascular disease or
cardiac arrhythmias. Baseline blood glucose will be recorded from patients with DM-II.
Time frame for this period was approximately 20-30 minutes per medical record review.
Area Specific Information includes:
a. Pre-Op Hold Area: existing cofactors, day of surgery medications, NPO status,
surgical procedure, review of systems, pain assessment.
b. Intra-Operative Data: Information obtained from electronic anesthesia record
(Innovian) includes intraoperative anesthetic, pain medications, muscle relaxants and use
or non-use of relaxant reversal medications.
c. Post Operative Data: Aldrete scores, PADSS scores, recovery times, incidence
of desaturations (02 Sat < 90%), pulse oximetry measurements, CPAP use, FS blood
glucose (DM-II pts.), hypertension documentation, medication treatments for pain and
any other co-existing factors (essentris computer record). Additional Data: Any
admissions to ICU will be followed and study data will continue to be documented until
discharge from ICU. (Electronic record)
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The Data collection protocol can be viewed in Appendix C.

STATISTICAL ANALYSIS
Specific Aims:
Aim 1. To examine (or characterize) sleep disturbed breathing (OSA),
hypertension, cardiovascular disease, diabetes, and postoperative recovery time, in a
cohort of patients undergoing surgical procedures.
Aim 2. To describe the relationships between sleep disturbed breathing (OSA),
hypertension, cardiovascular disease, diabetes, and postoperative recovery time among a
group of patients undergoing surgical procedures.
Aim 3,4, 5- Analyze the covariance of independent variables within the two
separate surgical groups.
Aim 6,7 - Examine the relationships that the independent variables (HTN, DM-II,
CVD) have on postoperative recovery time. The dependent variable of postoperative
recovery time (PORT) will be examined as a categorical variable (PORT longer or not)
Research Questions:
1). Examine the relationship of OSA patients with incidence of HTN, DM-II, Cardiacarrhythmia, CVD, and BMI having elective surgery under general anesthesia.
2). Examine the relationship of Non-OSA patients with incidence of HTN, DM-II,
Cardiac arrhythmia, CVD, and BMI having elective surgery under general anesthesia.

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

46

3). Examine the relationships between patients with OSA and prevalence of HTN,
Cardiovascular Disease, DM-II, GERD, gender, age, BMI, surgical procedure
compared to a group of non- OSA patients after elective surgery under GETA.
4). Characterize postoperative recovery time of OSA patients with incidence of HTN,
DM-II, Cardiovascular Disease, BMI and GERD having elective surgery under general
anesthesia.
5). Characterize postoperative recovery time of Non- OSA patients with incidence of
HTN, DM-II, Cardiovascular Disease, BMI and GERD having elective surgery under
general anesthesia.
5). Examine which predictors (HTN, Cardiovascular Disease, DM-II, BMI, GERD,
surgical procedure) account for explained variance in Post Operative Recovery Time.
6). Examine the relationship between severity or degree of OSA (mild, moderate and
severe) and length of postoperative recovery time.
Descriptive statistics were computed for demographic data such as age, gender,
marital status, medications, and incidence of sleep study. Descriptive statistics were
incorporated to examine pain occurrence, type of surgery and length of surgery.
PROTOCOL
The primary investigator (PI); a privileged ad working staff member in the
preoperative,main operative, and postoperative areas of NMCSD; with granted permitted
access to the medical records of study participants for the duration of the data-collecting
period. IRB approved co-investigators had authority to review pre-operative,
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intraoperative, and postoperative data from identified subjects. Incorporating coinvestigators ensured maximum enrollment, accuracy and accountability of the data.
Study integrity is vital for data accuracy and validity.

PROTECTION OF HUMAN SUBJECTS
The collection of non-invasive medical record data involves a minimal risk to subjects.
"Minimal risk" is defined as risks no greater than those experienced in everyday life. An
inclusion criterion for this particular study involved the subjects electing to have a
surgical procedure requiring general anesthesia. The surgeon and anesthesia provider
had already obtained the subjects consent for surgery with general anesthesia. Therefore
no additional risk is incurred as a participant of this study. All safety precautions,
procedures, and requirements ensured for the preoperative, intraoperative and
postoperative portions of this study were maintained. Direct consent for record review
was not required; IRB approval was obtained and documented as phase II component of a
Phase I preliminary study. Phase I: "STOP BANG TOOL TO DETECT
OBSTRUCTIVE SLEEP APNEA FOR THE PERIOPERATIVE PATIENT"
SAFETY PRECAUTIONS AND EMERGENCY PROCEDURES

The data for this study will be obtained from medical records from surgical
participants from the Naval Medical Center San Diego, a large Naval Medical Training
Facility. The principal investigator is a Naval Officer all HIPPA mandates and security
measures were incorporated to protect the privacy of all medical information obtained for
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this study. To ensure confidentiality all data was labeled with a unique subject identifier
that linked the subject with the data, and only the investigators involved in the study had
access to this link. No personal health information was attached.

DESCRIPTION OF THE SYSTEM FOR MAINTENANCE OF RECORDS

Sources of data for this study included the STOP-BANG, Aldrete protocol, and
Anesthesia Information Management System (AIMS). All instruments were coded using
each subject's assigned number. The master-coding list was kept in a locked file in an
assigned office in the anesthesia department at NMCSD and only the investigators
involved in the study had access to this data. Data was entered into a password-protected
computer. The only link to the subject's identity was by unique subject identification
number. No protected health information was on any of the data collection forms or
computer files.

Research protocols were maintained in a computer data password protected.
Completed protocols were stored in compliance with SECNAVINST 3900.39C and
BUMEDINST 3900.6B. Only the investigators had access to the master list. No
protected health information was placed on any of the psychometric instruments. These
measures ensure compliance with HIPAA standards and those of the Clinical
Investigations Department (CID) at NMCSD.
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TABLES
Table 1. Pre-Post STOP-BANG & DX OSA

PRESTOP
DATA

7.50%

92.50%

NS

POST STOP
DATA

37.60%

62.40%

P< 0.001

COFACTOR
DATA

32.60%

67.40%

P< 0.001

Table 2. OSA vs. Non-OSA & Amount Medication

COFACTOR

2.07

1.53

1.91 41

MEDICATIONS

1.92

1.13

2.64 40

P<
0.05
P<
0.01

283.76

235.75

1.76 40

P<
0.05

TIME
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Table 3. Logistic Regression: Cofactors and effects on OSA
Variables In the Equation
95% C.I.for
EXP(B)
S.E.

B
Step 1* AirWayProblem

Wald

Exp(B)

Sig.

df

Lower

Upper

1.884

.638

8.714

1

.003

6.582

1.884

23.001

HTN

1.017

.528

3.709

1

.054

2.766

.982

7.787

CAD

-.132

.536

.060

1

.806

.877

.307

2.505

Diabetes

-.045

.618

.005

1

.942

.956

.284

3.212

.488

3.064

GERD
Constant

.201

.469

.183

1

.669

1.222

-4.537

1.634

7.708

1

.005

.011

a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD.

Table 4. Linear Regression: Cofactors effect PACU Time.

Model
1
(Constant)

Unstandardized Coefficients
Std. Error
B
475.705
-202.568

140.381
48.910

CAD
Diabetes

56.731
63.708

47.692
56.032

GERD

-15.944

42.381

AirWay Problems

-27.213

55.520

HTN

a. Dependent Variable: Total PACU Time

Standardized
Coefficients
Beta

t
3.389

Sig.
.001
.000

-.453

-4.142

.125

1.190

.115

1.137

.237
.258

-.036
-.047

-.376

.708

-.490

.625
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FIGURE 1. STARLING RESISTOR MODEL
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FIGURE 2. SLEEP ANEA CYCLE.
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APPENDIX A.
STOP-Bang Scoring Model

1. Snoring
Do you snore loudly (louder than talking or loud enough to be heard through closed
doors)? Yes No
2. Tired
Do you often feel tired, fatigued, or sleepy during daytime? Yes No
3. Observed
Has anyone observed you stop breathing during your sleep? Yes No
4. Blood pressure
Do you have or are you being treated for high blood pressure? Yes No
5. BMI

BMI more than 35 kg/m2? Yes No

6. Age

Age over 50 yr. old? Yes No

7. Neck circumference Neck circumference greater than 40 cm? Yes No
8. Gender

Gender male? Yes No

High risk of OSA: answering yes to two or more items.
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APPENDIX B.
Modified Aldrete Scoring
Activity Able to move four extremities voluntarily on command 2
Able to move two extremities voluntarily on command 1
Able to move no extremities voluntarily on command 0
Respiration Able to breathe deeply and cough freely 2
Dyspnea or limited breathing 1
Apneic 0
Circulation BP ± 20% of pre-anesthetic level 2
BP± 20 - 49% of pre-anesthetic level 1
BP ± 50% of pre-anesthetic level 0
Pulse Rate Pulse ± 20 beats of pre-sedation rate 2
Pulse± 50 to 21 beats of pre-sedation rate 1
Pulse>± 51 beats of presedation rate 0
Consciousness fully awake 2
Arousable on calling 1
Not responding 0
02 Saturation Maintains baseline saturation on room air 2
Needs 02 to maintain >90% saturation 1
02 saturation<90% with 02 supplement 0
• Patients with an Aldrete score of two (2) points or more below baseline must be referred
to the physician responsible for the procedure for further evaluation.
• ** Patients equal to baseline post-procedure will be discharged from the procedure area
as in 5.0 of the Sedation/Analgesia Policy
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Abstract

Introduction: According to the American Heart Association, fifteen million adults are
affected by obstructive sleep apnea (OSA).1 Chung et al.5"6 developed, piloted, and
validated the STOP-BANG questionnaire as an OSA screening tool for surgical patients
at preoperative clinics. This questionnaire is used to assist the perioperative team with
routine screening for OSA. The national incidence of sleep apnea is 25% for men and
10% for women. At Naval Medical Center San Diego (NMCSD) the current incidence of
sleep apnea is 11%. This study was designed to evaluate the effects of implementing the
STOP BANG tool in preoperative clinics to identify undiagnosed OSA surgery patients.
Design and Methods: Pre and post quasi-experimental time series design project to
include two phases: Phase One: pre-data collection; Phase Two: pre-operative assessment
form and post-data collection. Five hundred and five charts were reviewed in phase one
and phase two for a total same size of 1010. Pre and post means were evaluated using a
student t-test; Chi-Square analyses was used to compare significance of OSA with
snoring, hypertension, age and BMI. A correlational analysis was utilized to see which
of the above variables had the most impact on sleep apnea. NMCSD IRB approved.
Results: There was no difference in demographic data. Pre identification of OSA patients
was 7.5%. Post identification of OSA patients was 37.6 %. Use of the STOP-BANG
tool increased OSA detection by 30.1%. Males and higher ASA classification were
correlated with OSA (p <0.00). The chance of identifying patients with OSA by using
the STOP-BANG tool increased by 75% (p<0.001).
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Conclusions and Implications: Anesthesia and surgery can affect sleep in combination
with the post-operative effects of anesthesia. Clinical suspicion of OSA may not be clear
to the anesthesia provider. Use of the STOP-BANG tool in anesthesia pre-screening will
increase patient safety.
Keywords: Obstructed Sleep Apnea, obese, STOP-BANG, apnea, hypercapnia,
hypoxemia, hypertension.

Introduction

According to the American Heart Association, fifteen million adults are affected by
OSA with a higher prevalence in obese men and patients suffering from cardiovascular
disease.1 OSA is a syndrome characterized by periodic, complete or partial obstruction of
the pharyngeal airway during sleep.2 Currently, an OSA screening tool is not used in the
perioperative setting to detect undiagnosed OSA in patients. The current incidence of
sleep apnea at NMCSD is 11% as indicated by quarterly quality assurance benchmark
indicators.
The OSA sufferer has complete cessation of airflow lasting longer than 10 seconds
during sleep despite continued respiratory efforts resulting in hypercapnia [increased
carbon dioxide (C02) levels] and hypoxemia.2 Usually the patient's apnea is terminated
when his or her C02 levels build up enough to stimulate the central nervous system
(CNS). Stimulation of the CNS arouses the individual enough to overcome the airway
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obstruction.3 Often the inspiratory effort is a forceful opening of the pharyngeal airway
and the airway is reestablished by loud snoring.4 Such respiratory efforts may be noted by
the individual's family as a loud snort or snoring. The apnea causes repetitive arousal
from sleep to restore airway patency, which may result in a poor sleep pattern with
daytime sleepiness or hypersomnolence.3

According to the National Sleep Foundation, one in four Americans are at high risk for
OSA, making the diagnosis the most prevalent sleep disorder.1 The "Gold Standard" for
OSA diagnosis is by polysomnography (PSG) to ascertain an apnea-hypopnea index
(AHI). PSG is conducted during a sleep study.5 The patient wears a sensor attached to
the head and body to record brain waves, eye movements, muscle activity and
cardiovascular activity while sleeping overnight in the sleep laboratory. AHI is the
calculated sum of apneic and hypopnea events experienced during each hour of sleep.
OSA is diagnosed by the presence of a least five obstructive apneas, hypopneas, or both,
per hour while the patient is sleeping. OSA is graded into three levels of severity: mild
(AHI greater than 5 but less than 15 events per hour); moderate (AHI 15 to 30 events per
hour); and severe (AHI of greater than 30 events per hour).6 PSG requires highly trained
personnel, complex equipment, and is costly to perform. According to Chung7, most
sleep study centers have long waiting lists requiring patients to wait for months for OSA
diagnosis and treatment. Due to patients' inability to have a PSG performed, there has
been a renewed clinical interest in finding a simple, easy tool to identify undiagnosed
OSA patients.
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The American Society of Anesthesiologist published guidelines recommending
that patients be screened for OSA risk prior to entering the perioperative suite.2
Typically, surgical patients have their preoperative clinic visit a few weeks prior to
surgery. OSA has been linked to hypertension, heart failure, atrial fibrillation, stroke,
myocardial infarction, and nocturnal sudden death.1 Chung7 also suggested that OSA is a
serious co-morbidity problem and needs to be evaluated for patients with a BMI greater
than 40. ASA guideline recommendations have produced a number of predictive clinical
models, but they usually require computer assistance and are not suitable for clinical
practice.7 As a result, several different questionnaires have been designed for OSA
screening. These questionnaires are the ASA checklist, Berlin questionnaire, STOP
questionnaire (snoring, tiredness during daytime, observed apnea, and high blood
pressure) and STOP-BANG Tool (which includes BMI, age, neck circumference, and
gender).7 The purpose of this project is to introduce the STOP-BANG tool into our
preoperative clinic to help identify undiagnosed OSA patients prior to surgery. The
utilization of the STOP-BANG tool in the pre-operative clinic will aid the perioperative
team in developing an appropriate anesthesia plan following ASA practice guidelines.
This should lead to an increase in OSA detection for undiagnosed patients thus increasing
patient safety.

Chung et al.5"6 developed, piloted, and validated the STOP-BANG questionnaire
to be used for surgical patients to assist the anesthesia provider with OSA screening. The
STOP questionnaire consists of four questions:

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

71

S: 'Do you snore loudly, louder than talking, or loud enough to be heard through
closed doors?'
T: 'Do you feel tired, fatigued or sleepy during the daytime?'
O: 'Has anyone observed that you stop breathing during your sleep?'
P: 'Do you have or are you being treated for high blood pressure?
The questionnaire uses a yes/no format to keep it concise and easy to use.7 If patients
answer yes to two or more questions, they are at high risk of suffering from OSA. If
patients have less than two positive answers, they are at low risk of having OSA. The
STOP questionnaire sensitivity for an AHI of more than 5, more than 15 and more than
30 events was 65.6%, 74.3%, and 79.3%, respectively.7
An alternative scoring tool described by Chung et al.5"6 is called the STOP
questionnaire and BANG-BMI tool. The BANG-BMI portion consists of B - BMI, A age, N - neck circumference, and G - gender. The addition of these patient characteristics
to the STOP questionnaire improves the sensitivity of the tool, detecting most patients
with OSA; particularly those with severe and moderate OSA.7 In the BANG portion of
the tool, BMI greater than 35, age older than 50 years, male gender, and neck
circumference greater than 40 cm are scored positively. Patients answering yes to three or
more items are considered at high risk for OSA.7
The BANG addition to the STOP questionnaire increased its sensitivity using an AHI
greater than 5 (mild), more than 15 (moderate), and more than 30 (severe) events to
83.6%, 92.9%, and 100%, respectively.7 A moderately high level of sensitivity and
specificity in surgical patients was demonstrated by the STOP questionnaire, and it was
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more sensitive for OSA detection in patients with severe (AHI > 30) or moderate (AHI >
15) OSA. A 100% predictive level could be found with patients with certain clinical
characteristics: male over 50, BMI greater than 35 and neck circumference greater than
40 cm.7 Chung et al.5"6 reported that incorporating BMI, age, neck circumference, and
gender (BANG) into the STOP questionnaire increases tool sensitivity for the
undiagnosed OSA patient. If the STOP-BANG questionnaire ranks a patient as low risk,
the patient can be excluded from having moderate to severe OSA.7
The STOP questionnaire is an easy to use screening tool to identify patients with
OSA. Incorporating BMI, age, neck size and gender into the STOP questionnaire
(STOP-BANG) further increases the predictive value for patients with severe to moderate
OSA. The STOP-BANG questionnaire will aid the perioperative team in evaluating the
patient for OSA and in developing an appropriate anesthesia plan following ASA practice
guidelines. The purpose of this study is to see if the STOP-BANG tool can increase the
identification of patients at risk for OSA, which will decrease their risk for complications
during anesthesia and improve patient safety.

Framework
The Iowa Model of evidence-based practice to promote quality preoperative care gives
a basic outline to help implement the STOP-BANG tool. The OSA diagnosis is the
clinical problem to be addressed, but the process of assessment also needs to be improved
within the clinical setting. Since current research supports utilization of an OSA
screening tool to identify potential OSA patients, the STOP-BANG tool will aid the
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anesthesia provider in following ASA practice guidelines for the peri-operative
management of these patients.

I n reviewing the literature, there are many case reports of difficult tracheal intubation
and cardio-respiratory consequences of OSA but very little research on patients with
OSA and their peri-operative mortality and morbidity.7 In a recent systematic review by
Chung et al.5"6, the evidence of the potential deleterious effects of anesthesia, sedatives
and analgesics are compounded for the undiagnosed OSA patient. The increased risk of
peri-operative adverse occurrences implies that the anesthetic management plan needs to
be patient specific. It is imperative for the anesthesia provider to meet the challenge of
maintaining an unobstructed patient airway and preventing perioperative complications.5
6

The ASA guidelines emphasize the significance of evaluation, detection and

preparation within the preoperative visit for the OSA patient when going for a surgical
procedure.2

Methods / Design
This study used a pre and post quasi-experimental time series design. One thousand
and ten patients were enrolled in two phases. Phase One was done before
implementation of the STOP-BANG tool. Phase Two was completed after
implementation of the tool. Subjects were recruited in the preoperative clinic.
Inclusion criteria consisted of the following: 18 years or older, scheduled to undergo
elective procedures in general surgery, urology, plastic surgery, orthopedics,
gynecology, ophthalmology and neurosurgery. The subject had to be able to read and
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write English, alert and oriented. Exclusion criteria consisted of the following:
subjects who were unwilling or unable to fill out the STOP -BANG questionnaire,
patients previously diagnosed with OSA or any other sleeping / breathing disorder, or
patients expected to have abnormal neurological functioning. While filling out their
anesthesia paperwork, preoperative nurses asked all patients who met inclusion
criteria to complete the STOP-BANG questionnaire. The STOP-BANG tool is
displayed in figure 1.

+ Do you have sleep apnea?
+ Do you use CPAP at home?

+
+
+
+
+
+
+
+
+

Scored Questions
1. Do you snore loudly? (louder than talking or loud enough to be heard
through closed doors]
2. Do you often feel tired, fatigued or sleepy during the daytime?
3. Has anyone observed you stop breathing during your sleep?
4. Do you have or are you being treated for high blood pressure or
have you been advised to be treated for high blood pressure?

+
+ High risk of OSA: Yes to 2 or more questions
+ Low risk of OSA: Yes to fewer than 2 questions
+
+ Additional questions:
2

+ Height cm
+ Age
(50)

Weight kg
Gender
(M)

2

BMIkg/m
(35 kg/m )
Neck Circumference cm
(40cm)

+
+ Values > those in parentheses increase sensitivity and
+ decrease specificity of test if included in determining likelihood of OSA
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Figure 1. STOP-BANG. Adapted from ASA practice guidelines.2

Every surgery patient was provided a pre-operative packet that included the STOPBANG tool. The pre-operative clinic nurse performed the final review of the patient's
paperwork. The nurse insured that the form was completed and measured the patient's
neck circumference. Two reviewers performed the baseline data collection before and
after tool implementation. The patient's characteristics were documented for baseline
data to assess for the current patient population total. Baseline data consisted of: gender,
age, weight (BMI), snoring, hypertension, tiredness, and obstruction; if the patient suffers
from OSA what is the severity; have they had a sleep study; if the patient denies OSA, is
there a suspicion by the anesthesia provider.
After implementation of the STOP-BANG tool, statistical analysis was done to
compare the percentage of pre and post OSA diagnosed patients and to establish a
baseline for OSA at the facility. Baseline data collected before tool implementation and
after patients completed the STOP-BANG questionnaire was compared using Chi-square
to test for differences in gender, age, weight (BMI), snoring, hypertension, tiredness, and
airway obstruction. The Chi-square test helps determine if the STOP-BANG tool detects
the undiagnosed OSA sufferer in the elective surgery population.
To determine the number of undiagnosed OSA patients seen by the pre-operative
clinic, a pre implementation chart review was performed using the facility's anesthesia
records. After orientation to the tool for all pre-operative clinic nurses and anesthesia
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providers, all elective surgery patients were asked to fill out the STOP-BANG
questionnaire which was placed in a pre-designated position within the chart.
Data collection related to the incidence of OSA in the population occurred over a threemonth period prior to program implementation and for several months post
implementation. All post-operative charts were collated within the chart house. The
charts remained within the chart room for 60 days or until completion by the providers.
During tool implementation, team members addressed any questions that arose. The
elective surgery population is a random cluster sample. The sample size was dependent
on the elective surgery schedule for the month. Chung et al.5"7 and Chung7 articles were
used to establish the sample size. Five hundred and five patient charts were evaluated in
the Phase One and Phase Two for a total sample size of one thousand and ten. Ten
percent was added to the sample size for lost data. The actual number fluctuated
depending on the rotational basis of surgery residents and deployment schedule of staff
surgeons. Actual tool performance was simple for patients and pre-operative nurses. Data
was entered into SPSS 19 to aid in data analysis. Nurses were trained to measure all
patients for neck circumference uniformly at the level of the cricoid cartilage.
A regression analyses model was utilized to see which variables impacted the dependent
variable post implementation sleep apnea. IRB approval was obtained at the primary
clinical facility and at the university campus.
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Table 1. Comparison of Baseline Data and Post STOP-BANG Tool Implementation
(N=1010)
Pre-

Post-

Implementation

Implementation

Male

61%

65%

NS

Female

39

35%

NS

Age

47.85

51.50

NS

BMI

27.32

28.76

NS

OSA

7.5%

37.6%

P<0.001

Hypertension

24%

43%

P<0.001

Snoring

2.6%

30.9%

P<0.001

Medications

1.13

1.92

P<0.01

PACU Time

235.75

283.77

P<0.05

Significance

diagnosed

Graph 1. Comparison of Positive and Negative Pre-Sleep Apnea Data vs. Post-Sleep
Apnea Data
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Post-Sleep Apnea Data

Positve

Negative
Negative

Table 2. Correlation Analyses Model Results Comparing the Impact of HTN, BMI and
Age on Sleep Apnea.

Coefficients*
Unstandardized Coefficients
Model
1

Std. Error

B
(Constant)

Standardized
Coefficients
t

Beta

Sig.

1.698

.268

6.344

.000

PoHTN

.321

.095

.328

3.391

.001

PoBMI
PoAge

-.110

.044

-.215

-2.478

.015

-.107

.042

-.243

-2.569

.012

a. Dependent Variable: PoSA

Results
This sleep apnea project was completed in two phases. In Phase one, five hundred
and five post-surgical charts were retrospectively reviewed for demographic and STOPBANG data. In Phase Two, five hundred and five surgical patients completed the
STOP-BANG tool during their preoperative visit, and their charts were retrospectively
reviewed for demographic and STOP-BANG data. Forty-five charts from each group
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were dropped due to lost data points. There was no difference in demographic data. Pre
identification of OSA patients was 7.5%. Post identification of OSA patients was 37.6
% (Graph One). Use of the STOP-BANG tool increased OSA detection by 30.1%
(p<0.001). Hypertension, snoring, patient medications and extended PACU times were
significantly different between the pre and post implementation groups (Table 1). Males
and higher ASA classification were correlated with OSA (p<0.001). There is a 75%
increased chance of identifying patients with OSA if the STOP-BANG tool is used
(p<0.001). A correlation analyses model was completed looking at the impact of
predictors on post implementation sleep apnea. The correlation model was significant,
and it appeared that hypertension was the most significant associated with sleep apnea
(p<0.001). BMI and patient age were also associated with sleep apnea, but not as
significant (p<0.015, 0.012) (Table Two).

Discussion, Conclusion and Implications
Chung et al.5"6 clearly states that the incidence of sleep apnea is 25% for men and 10%
for women. Before this evidence-based project was undertaken, we were postoperatively
identifying 11% of sleep apnea patients. During this project, we were able to identify
37.6% of our surgical population who had sleep apnea. This was a 26.6% improvement
over our prior clinical assessment. We obtained results similar to Chung et al.5"6 in
identifying 28.3% of men and 9.3% of women. This project also confirmed Sommers et
al.1 work that cardiovascular issues such as hypertension may be a predictor for sleep
apnea as well as snoring and may lead to prolonged recovery time as shown in our work.8
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Future research is needed to confirm which co-factors impact recovery time in sleep
apnea patients. In conclusion, anesthesia and surgery can affect sleep apnea in
combination with the post-operative effects of anesthesia.8 Clinical suspicion of OSA
may not be clear to the anesthesia provider. The use of the STOP-BANG tool is an easy
addition to anesthesia pre-screening and increases patient safety. OSA syndrome impacts
each phase of the anesthesia plan.3 In the pre-operative phase, the nurse or anesthesia
provider may be the one to assess the patient for OSA prior to surgery. Within the
operative phase, the anesthesia provider in charge ultimately decides on the type of
anesthesia and pain medicine the patient is provided during their procedure. Within the
recovery phase, the patient needs balance in pain control, comfort, and airway patency.3
The recovery room nurse monitors the patient for depressed ventilatory responses that
can occur after anesthesia. Typically, hypercarbia and hypoxemia triggers the patient to
arouse after anesthetics and analgesics, but the OSA sufferer has a depressed response.2
Using a screening tool can facilitate a diagnosis of OSA, especially for patients who are
not aware they have it.3 The pre-tool and post-tool evaluation found that 26.6% of
patients were undiagnosed within our pre-operative clinic. The ultimate long-term goals
of utilizing the STOP-BANG tool is reducing prolonged recovery room stays by 50% and
reducing unplanned over-night admissions by 75%. Whether or not this is accomplished
will be determined in future studies. In a recent by Chung et al.9, patients with OSA were
found to have an increase in postoperative complications.8 Ultimately, increasing patient
safety by pre-screening potential OSA patients will decrease our institutional mortality
rate for undiagnosed patients to zero. The use of a screening tool for OSA will aid the
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anesthesia provider in the decision-making needed to safely treat these patients intraoperatively.2
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ABSTRACT
Significance/Background: Obstructive Sleep Apnea (OSA) is the most common
disturbance during sleep affecting 30% of the population. The occurrence of
moderate/severe OSA is estimated at 11.4% in men and 4.7% in women. OSA is caused
by repetitive partial or complete obstruction of the upper airway with apnea episodes.
OSA is prevalent in western society, yet is frequently undiagnosed due to lack of
knowledge of the disorder. This population presents a challenge during the peri-operative
period due to increased risk for several complications. Of particular interest to Nurse
Anesthetists, are respiratory complications that result in delayed emergence from
anesthesia, delayed post-operative recovery, increased apneic episodes, hypoxemia, and
death. Examining duration of recovery periods between the two OSA groups will help
determine if patients with additional cofactors benefit from longer post-operative
monitoring or modification of anesthetic technique.
Methods: An observational correlation design to include a non-randomized convenience
sample of two groups. Comparisons will be made between groups regarding cofactors,
complications and duration of postoperative recovery times. Patients having elective
abdominal surgery under general anesthesia at a Military Treatment Facility will be
identified. OSA status will be determined based upon Sleep Studies, or STOP-BANG
tool criteria. Medical, surgical, and anesthesia data will be reviewed. Total recovery times
and pre-existing disease documented. Multiple Logistic and Regression testing will
compare the effects of cofactors on postoperative recovery times. Chi square analysis will
evaluate relationship of individual cofactors with OSA and Non-OSA patients. T-test
analysis will compare demographic information. P score of < .05 will be considered
significant.
Results: This study indicated significant correlation with higher number of cofactors
amongst patients diagnosed with OSA (p< 0.012). Increased incidence of higher ASA
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classification in OSA diagnosed patients; (p< .017) extended PACU stay time in OSA
diagnosed patients; (p= 0.05) and Unplanned admissions in OSA patients; (p=. 007).
Patients with OSA use a higher number of prescribed medications as compared to nonOSA patients, they have a 3.36 greater chance of having hypertension as an additional
cofactor (p< .05) and they were 8.75 times more likely to experience airway difficulties
or complications with general anesthesia when compared to non-OSA patients (p< .05).
Multiple logistic regression testing demonstrated increased incidence for both airway
difficulties (p= .003) and Hypertension (p=. 054). Multiple linear regression results
indicate one cofactor HTN as a significant predictor for PACU stay time. (R2= .179, R2^
= .136, F (1))
Implications: Findings will lead to optimum monitoring, management; recovery measures
and anesthesia techniques that will prevent extended postoperative periods and reduce or
eliminate postoperative complications of OSA.
Key Words: Obstructive Sleep Apnea, Cofactors, STOP-BANG
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Introduction

Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep
affecting 2-26% of the general population. 12 The occurrence of moderate to severe OSA
is estimated to be 11.4% in men and 4.7% in women. OSA is a prevalent problem in
Western Society estimated to occur between 1 to 9% in patients presenting for surgery,
yet it is frequently undiagnosed due to lack of awareness or knowledge of the disorder.3-4
OSA is caused by repetitive partial or complete obstruction of the airway during sleep.
Diagnosis of OSA is determined by the occurrence of airway obstruction during sleep
with apnea periods lasting greater than 10 seconds for five or more times per hour; with a
decrease in arterial oxygen saturation (Sa02). These events are known as apnea/hypopnea
episodes and the measurement of episodes is referred to as the Apnea-Hypopnea Index
[AHI]. The degree of severity of the disorder is determinate of the number of AHI per
hour. AHI: 5-15 mild, > 15-30 moderate and > 30 severe.3 4
A polysomnography otherwise known as a sleep study is recognized as the "Gold
Standard" for the diagnosis of OSA. Polysomnography data defines the degree of severity
of the condition and number of apneic episodes. Unfortunately polysomnography is time
consuming; patients are reluctant to participate in them; they require an extended stay in
the sleep lab; and they are expensive. Medical professionals have become more aware of
OSA as a significant disorder with resulting adverse effects for their patients. More
physicians are consulting to sleep labs to ascertain severity and the availability of
appointments have become more limited. Unfortunately for the OSA patient,
polysomnography cannot be obtained rapidly and in the case of surgical interventions that
may be required for urgent or emergent disorders OSA may go undetected. 12

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

87

Subsequently, the OSA patient population presents a unique challenge during the peri
operative period due to an increased risk for lack of identification and subsequent life
threatening complications. Of particular interest to the Nurse Anesthetist, are the
respiratory complications that can result in delayed emergence from anesthesia, delayed
postoperative recovery, increased apneic episodes, hypoxemia, cardiac disturbances and
ultimate death in this patient population.
Obesity, gender, snoring and age have demonstrated to be strong indicators of
occurrence for OSA. Hypertension, cardiovascular disease, diabetes and stroke are
prevalently reported as confounding and coexisting factors.5 In 2003 Netzer at al,
surveyed OSA patients in twenty-six US primary care clinics and fourteen European
primary care clinics comparison of the results demonstrated similar symptoms of age,
gender distribution and hypertension.6 Obesity was common among both sets of OSA
patients although the incidence was much higher in the United Sates than in Europe.
Another study obtained in Spain by Duran et al, 2001 reported linkages between OSA
and hypertension after interviewing over 2,000 patients.7 Elevated blood pressure and
refractory bradycardia followed by abrupt tachycardia are cited as predominate
cardiovascular effects of OSA. The hemodynamic instability seems to be related initially
to hypoxemia from the airway obstruction, and then sudden arousal as the patient
awakens to breath. The rapid fluctuation of vaso-activity is thought to be responsible for
the incidence of cardiac arrhythmias, the development of chronic arterial hypertension,
the occurrence of myocardial infarction and sudden cardiac death.8
The severity and incidence of documented post surgical complications from patients
with moderate to severe OSA is significant. Yet, most of the informational data of
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incidence, occurrence, surgical complications and treatment of the OSA patients come
from case reports and retrospective reviews not evidenced based scientific studies.
The American Society of Anesthesiologist (ASA) developed guidelines in 2006, based
on Level IV evidence and expert consensus reports to address the identification and
treatment needs of the OSA patient. The ASA consultants reached agreement on
treatment criteria for most simple outpatient and minor orthopedic surgical procedures
but could not find consensus regarding more invasive surgeries. The guidelines propose
that for more invasive surgery certain factors need to be considered when determining
postoperative risk for the OSA patient these included: status of sleep apnea, (treated or
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are
they appropriately managed), type of surgery, and anesthesia modality.1-2
Key experts in the diagnosis and treatment of the OSA patient acknowledge poor
quality of evidence in an article from the American Academy of Sleep Medicine; "the
scientific literature regarding perioperative risk and best management techniques for OSA
patients was scanty and of limited quantity".9
The ultimate goal for all Nurse Anesthetists is to provide the safest, highest quality
anesthetic management and care to their patients. If Nurse Anesthetists can identify and
understand the coexisting factors creating the most risks for perioperative complications
in the OSA defined patient they can better prepare themselves to manage those risks and
provide optimum care. They can select anesthetic practices that minimize risk and
maximize safer outcomes.
Development of more concise and accurate techniques to eliminate the factors
producing increased risk for this population could be incorporated. Valid criteria for
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preoperative identification of the OSA patient could be developed and preoperative
management techniques could be identified. Established guidelines and protocols could
be created to eliminate most if not all risk factors. The complete elimination of incidence
and occurrence of morbidity and mortality for the OSA patient in the perioperative
environment would be the ultimate goal.
The purpose of this study is to identify the preexisting factors that significantly affect
postoperative recovery times between patients with Obstructive Sleep Apnea compared to
patients without Obstructive Sleep Apnea undergoing abdominal surgical procedures.
Specific aims to determine the incidence and occurrence of pre existing cofactors:
hypertension, coronary artery disease, and diabetes will be evaluated. Secondary aims
are to determine if relationships of occurrence exist between the co-existing factors. If
relationships of co-existing factors are determined can they be further categorized as
positive or negative relationship?
OSA will be defined utilizing the STOP-BANG screening parametric, a concise and
simple to use screening tool specifically developed to assess OSA criteria. Stop-Bang is a
12-question tool that has been implemented and validated for use in defining OSA
criteria in a surgical patient population. Obstructive Sleep Apnea is defined by a greater
than 5 score determined from responses to the 12 question measure. 12
An English physiologist Ernest Starling identified a theoretical phenomenon of vessel
capacitance as influenced by flow, forces and pressure. This Theory became known as
the Starling Resistor Theory and explains the function of fluid flows through the coronary
arteries. The Starling Resistor Theory is offered as a theoretical framework to compare
and contrast airway physiology and function within the normal adult airway and in the
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OSA airway.
The starling resistor model can be readily applied to describe flow in the upper
airways. The concept provides an excellent explanation of airway dynamics as influenced
by changing forces or pressures. A resistor is described as a collapsible tube passing
through a chamber that is capable of having it's pressure changed. For adaptation
purposes we can identify the oropharynx as the tube and the surrounding tissue of the
neck as the chamber. If the oropharynx remains open then airflow through will be
determined by the pressure differences from the two sides of tissue within the neck; from
the pressure above; the proximal region of the nose or mouth and from the pressure
below; the distal portion of the trachea.
The main characteristic dysfunction of OSA is obstruction of airflow. The patient with
OSA has recurrent apneic events that are the result of a closed or "blocked" airway that
occurs during sleep. To understand the co-existing factors that may contribute to the
adverse affects of OSA we must first understand the anatomic and physiologic process
that defines OSA. The airway of the OSA patient presents differently than that of a
typical adult airway. An OSA patient's airway is smaller and narrower in contrast. The
OSA airway has a more lateral axis while the typical adult airway is more horizontal. An
excess of redundant tissue causes this variant. In fact a definitive feature of OSA patients
is an increased neck circumference or "thick neck". When sleeping the oropharyngeal
muscles of the adult airway are relaxed and pharyngeal narrowing occurs and there is
increased negative inspiratory pressure especially during rapid eye movement (REM)
sleep. Additional inspiratory negative pressure is generated by diaphragmatic excursion
and pharyngeal dilator muscle activity is incorporated as a compensatory mechanism that
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maintains airway patency in the normal adult. In the OSA patient pharyngeal dilator
muscle activity maintains patency during awake periods but the muscle activity is lost
when the OSA patient is asleep.
Excessive or adipose tissue in the neck of the OSA patient surrounds the oropharynx
and compresses the airway making muscular activity less effective. Increased negative
inspiratory pressure along with snoring, which can cause vibratory trauma, can further
enhance upper airway narrowing. 11
The tissue pressure (Ptissue) corresponds directly to the pressure with which the
surrounding tissues of the oropharynx constrict the upper airway. A high opening
pressure (Pproximal) will assist in overcoming the collapsing pressure of tissue (Ptissue).
A low or negative pressure below the vocal cords (Pdistal) that occurs as a result of the
inspiratory effort will contribute to airway collapse if Ptissue is elevated. When
sufficient muscular tone is operative in tissues surrounding the collapsible tube, in effect
"lifting the tissue" away from the collapsible portion Ptissue does not contribute to
airway collapse.12 In the OSA patient arousal is essential for airway patency and
survival.
Theoretical Perspective
Starlings Resistor Theory was formulated to explain the properties of vascular
compliance and resistance forces. The theory has already been established and accepted
as defining the properties of fluid flow through blood vessels, and vascular circulation.
Although the coexisting factors of hypertension and cardiac disturbances in the OSA
patient are not fully understood an association with flow, increased pressure and
collapsibility may offer an explanation using Starling's Resistor Theory. Applying this
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theoretical framework for both airway and hemodynamic pressures is appropriate and
could indicate symbiotic relationships.
Fig 1. Starling Resistor Theory Diagram

Pd (distal)=upstream pressure, Pp (proximal)=downstream pressure and Pt
(tissue)=pressure in the box.12
Lack of oxygenation leads to hypoxemia and hypercarbia. Increased levels of C02
stimulate chemoreceptors within the CNS, which in turn release neurotransmitters
promoting arousal. Reflex response activates pharyngeal dilator muscles and airways
open, ventilation is returned. 4
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Fig 2. Sleep Apnea Cycle
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The risk of serious postoperative complications has been previously addressed in
regards to obstructive sleep apnea alone and with coexistence disease. Most OSA patients
have sleep disorders involving both REM and Non REM sleep. Nocturnal apneic events
coupled with preoperative anxiety; common prior to surgery, leads to overall poor sleep
quality, and sleep deprivation prior to surgical events. This causes many patients to
experience post-operative REM rebound characterized by increased episodes of airway
atony and subsequently airway collapse. This phenomenon can occur up to the third or
fourth postoperative day when patients have returned home.13 Benumof 2004, found
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supporting evidence in the postoperative setting, that sleep mechanics were disturbed due
to the requirement for increased analgesia for surgical pain. Analgesia through the first
three days after surgery tended to incur a life threatening apnea from drug-induced sleep.
He also described rebounds in REM sleep originating from poor quality sleep this was
believed to increase the danger of a detrimental natural deep sleep- induced apnea. He
suggested that patients with OSA are at risk of prolonged apnea during sleep for up to
one week in the postoperative period.14
Correlations between hypoxic events and episodes of recurrent oxygen desaturations
associated with adverse outcomes have been reported. Gupta et al (2001) examined
procedure specific complications in the post operative period and found that OSA
patients experience significantly more occurrence of complications than the group
without OSA. Complications included acute hypercapnea, PaCo2 >45, episodic
desaturations reflected by Sp02 <90% with witnessed apneic events mmHg; arrhythmias,
MI, or infarction, and delirium.15
In the United Kingdom a mailed survey was provided to a group of anesthetists to
define perioperative care of adults with OSA: Perioperative complications included 34%
difficult intubations, 47% difficult ventilations, 24% cardiovascular instability, difficult
analgesia in 41%, difficult extubation 13%, postoperative apnea 46%, required
reintubation 27%, unplanned ICU admission 23%, and acute cardiac events 25%.16
These findings support the need for accurately assessing the postoperative status of
OSA patients and determining criteria for risk assessment. Studies have shown strong
relationships between the numbers of oxygen desaturations episodes within the post
anesthesia care unit to occurrence of adverse events.
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Questions could be posed regarding the causes of the postoperative complications.
OSA attributed events such as: Hypoxia, Hypopnea, Hypercapnea, snoring etc. Are these
conditions independently caused by the OSA disorder? Or is their synergistic
components with other cofactors (HTN, Diabetes, CAD) that creates the adverse events?
Does the OSA patient with one or more cofactors have more adverse events and do they
require a longer PACU stay? There currently is no clear explanation. It would be valuable
information for the anesthesia provider and other health care providers to know the most
significant cause of adverse events in the OSA patient.

METHODOLOGY
An observational correlational design method will be utilized for determining the
relationship of postoperative ambulatory care unit (PACU) stay times and hypertension
(HTN), diabetes (DM-13), coronary artery disease, and body mass index (BMI) in
obstructive sleep apnea (OSA) patients.

Sample

A purposive sample of active duty, retired, or family members of military service
members having consented to elective abdominal surgery at the Naval Medical Center
San Diego (NMCSD) and received a score of 5 or greater from preoperative evaluation
using the STOP-BANG screening measurement.
Inclusion Criteria consists of males and females 18 to 65 years, who have elected to have
general anesthesia for abdominal surgery, category ASA I & II. Exclusion Criteria will
consist of members above who have pre-existing pulmonary disorders (COPD, etc.),
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neurological dysfunction, delayed or decreased cognitive function, recent MI.
Demographic data will include age, gender, BMI, medications and type of surgical
procedure.
Sample Size Calculation
For the purpose of this study which is to determine if identified obstructive sleep apnea
(OSA) patients have longer PACU recovery times as compared with non-OSA patients
undergoing abdominal surgery and if their is an association between OSA patients with
pre-existing factors (HTN, Diabetes, Coronary Artery Disease, BMI) and extended
PACU recovery times. A multiple logistic regression will be used to analyze the data.
Several mathematical formulas exist along with computer program power analysis
software to help determine appropriate sample size. These formulas and software
programs assure that the number of participants selected for the study provide enough
information to establish a valid correlation of event and outcome. Published studies have
cited occurrence of OSA in western populations within the range of 23-38%. '"2'3'14'17
More specific approximation of incidence of OSA in surgical patients fall within 24-26%.
1-2

The sample size for this study will be based on the consensus of data establishing a

26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and Katz (2006)
guidelines of ten subjects per predictor, 50 subjects with OSA would be a minimum.
Considering the incidence of OSA in the surgical population of 26% the estimated
sample size for this study is 119 subjects.

18,19

Data collection for this research will

consist of a medical record review of patients from the Naval Medical Center San Diego
who have undergone an elective abdominal surgery utilizing general anesthesia.
Preoperative, intraoperative and postoperative data will be evaluated for study criteria.
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Measure of Obstructive Sleep Apnea
OSA will be defined utilizing the STOP-BANG screening parametric, a concise and
simple to use screening tool specifically developed to assess OSA criteria. The STOP
Bang Questionnaire is made up of 4 yes/no questions related to:
1. Snoring 2. Tiredness 3. Observed Apnea during sleep 4. High Blood Pressure. It is a
self report, choice (yes/no) paper and pencil scale that takes an estimated 1 minute to
complete.1
Aldrete Score Measurement

Protocols are utilized to immediately assess a patient's recovery from anesthesia after
surgery. A universally used scale is the Aldrete scale, which scores the patient on
mobility, respiratory status, circulation, consciousness, and pulse oximetry. The Aldrete
score was formulated in 1970 and modified in 1992. Aldrete uses a rating scale of 0 thru
2 to score the five physiological criteria previously listed. A score of 2 in each category is
considered best in all areas. The patient is discharged from the PACU when they meet
the established criteria for discharge an overall score of 9. This measurement will be
utilized to determine overall PACU stay times.

Results

Findings from our pilot study of 100 patients demonstrated that OSA patients were
8.75 times more likely to experience airway difficulties or complications with general
anesthesia when compared to non-OSA patients (p< .05). We found a significant
correlation with a higher number of cofactors (co-existing disease) amongst patients
diagnosed with OSA (p< 0.012) as compared to non-OSA patients. An increased
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incidence of higher ASA classification (p< 0.017); extended PACU stay time (p< 0.05);
and unplanned admissions (p<. 007) was also found in OSA patients when compared to
non-OSA patients.
In addition patients with OSA had a higher number of prescribed medications as
compared to non-OSA patients. OSA patients had a 3.36 greater chance of having
hypertension as an additional cofactor (p< .05)

Correlation

OSA DX YES

OSA DX NO

SIGNIFICANCE

7.50%

92.50%

NS

POST STOP
DATA

37.60%

62.40%

P< 0.001

COFACTOR
DATA

32.60%

67.40%

P< 0.001

PRESTOP DATA

Table 1. Pre-Post STOP-BANG & DX OSA.

COFACTOR

2.07

1.53

1.91

41

P< 0.05

MEDICATIONS

1.92

1.13

2.64

40

P< 0.01

283.76

235.75

1.76

40

P< 0.05

TIME

Table 2. OSA vs. Non-OSA amount medications.
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Multiple logistic regression testing demonstrated increased incidence for both airway
difficulties (p= .003) and Hypertension (p=. 054). Multiple linear regression results
indicate one cofactor HTN as a significant predictor for PACU stay time. (R2= .179, R2adj
= .136, F (1)
Table 3. Logistic Regression: Cofactors and effects on OSA
Variables In the Equation
95% C.l.for
EXP(B)
B
Step

1a

S.E.

Wald

df

Sig.

Exp(B)

Lower

AirWayProbiem

1.884

.638

8.714

1

.003

6.582

1.884

23.001

HTN

1.017

.528

3.709

1

.054

2.766

.982

7.787

CAD

-.132

.536

.060

1

.806

.877

.307

2.505

Diabetes

-.045

.618

.005

1

.942

.956

.284

3.212

.201

.469

.183

1

.669

1.222

.488

3.064

-4.537

1.634

7.708

1

.005

.011

GERD
Constant

a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD.

Table 4. Incidence of cofactors with OSA.
Coefficients3

Model
1

Upper

Unstandardized
Coefficients
Std. Error
B
475.705
140.381
48.910
-202.568
56.731
47.692
56.032
63.708
-15.944
42.381
55.520
-27.213

(Constant)
HTN
CAD
Diabetes
GERD
Air Way
Problems
a. Dependent Variable: Total PACU Time

Standardized
Coefficients t
Beta
3.389
-.453
-4.142
.125
1.190
.115
1.137
-.036
-.376
-.047
-.490

Sig.
.001
.000
.237
.258
.708
.625

OBSTRUCTIVE SLEEP APNEA EFFECT COFACTOR ON PACU RECOVERY

100

Discussion
In Phase I of our study, utilizing the STOP-BANG measurement tool demonstrated
high predictability in defining OSA in patients with both unknown and suspected OSA
condition. Complications associated with OSA can be severe and life threatening. These
complications include: hypoventilation, hypoxia, airway obstruction, intubation
difficulties, and a higher incidence of myocardial infarction. These complications can
occur intra-operatively, post operatively and during the PACU stay period. There
currently exists wide diversity in the postoperative management of the OSA patient.
There is a consensus that the OSA population requires more stringent anesthesia
management during induction but even more critical is the post operative period while
the OSA patient is still under the effects of residual anesthetic agents and narcotics.
Practice guidelines vary widely within medical facilities in the anesthesia management of
OSA patients postoperatively. The average PACU stay time for the non -OSA patient is
under 1 hour. The duration of time that the OSA patient should be observed in the PACU
is not well defined due to the physiologic changes that occur in the OSA patient airway
and respiratory mechanics while under anesthesia and sedation.
The importance of our OSA studies are their validation of instruments that can provide
valuable preoperative information that would aid identification of surgical patients with
both known; and more importantly unknown OSA. Phase II study goes further
identifying the incidence and significance of co-existing factors (cofactors) that influence
the PACU recovery time of OSA patients as compared with non-OSA patients. Valuable
information determined from our studies can provide guidelines and protocols
streamlining and specifying the intraoperative management for the OSA patient in a
manner that minimizes complications. Significant cofactors can be identified and
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appropriate optimization measures can be applied. Postoperative measures and protocols
could be developed to reduce the risk factors and provide for safe analgesia that inhibits
heavy sedation while promoting optimum oxygenation to eliminate adverse events and
extended recovery times.

Limitations
The obvious limitation in our study was our sample size of 110 subjects. The data for
our retrospective study was facilitated by the use of an anesthesia information
management system (AIMS) that was incorporated 18 months prior to this study.
Although utilization of the AIMS enabled a concise and consistent source of all data
elements for our study, the number of electronic anesthetic records was not as robust as
we would have liked. Further studies involving a greater number of records that duplicate
our results would not only validate our study but may also demonstrate additional
cofactors influencing OSA. Additionally, we did not incorporate physiologic monitoring
such as capnography or cerebral oxygen saturation. Physiologic measurements such as
carbon dioxide (Pco2) and cerebral oxygenation could be incorporated to further
investigate the synergistic relationship of hypoxia and hypopnea in the OSA patient with
hypertension, coronary artery disease and diabetes.

Implications
By better understanding factors that increase the adverse events of OSA, we can better
prepare for or even prevent bad outcomes. Identifying characteristics inherently
consistent in patients with OSA will enable anesthesia to alleviate risks, optimize
outcomes by implementing supportive measures and anesthesia techniques that will
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decrease the occurrence of hypoxemia, apnea/hypopnea, hypertensive and cardiac events.
Preoperative assessment of all surgical patients using validated instruments would
identify surgical patients with both known OSA and more importantly identify those that
are unknown. Cofactors can be identified and appropriate optimization measures can be
applied.
Future Research
Once all mitigating factors are better understood anesthesia providers can direct efforts
for increased study. Additional studies related to the physiological and neurological
components that affect hypopnea; hypoxia and vaso-activity could provide further insight
into the obstructive processes that cause the complications in the OSA patient. Optimum
anesthetic measures and techniques could be investigated and incorporated throughout
the continuum of perioperative care. Protocols could be developed as guidelines to
provide safer and consistent quality care. Intraoperative management could be
streamlined and specified for the OSA patient in a manner that minimizes complications.
Postoperative measures and protocols could be developed to improve the care for the
OSA patient; eliminating the risk factors and provide for safe analgesia that inhibits
heavy sedation while promoting optimum oxygenation and pressure if need be to support
airways and eliminate adverse events. Patient can be advised regarding self-care
measures that can enhance their quality of life. Most important for the anesthesia provider
is the further identification of all contributing and co-existing factors.
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Introduction

Obstructive Sleep Apnea (OSA) is the most common disturbance during sleep
affecting 2-26% of the general population (Chung et. al, 2008). The occurrence of
moderate to severe OSA is estimated to be 11.4% in men and 4.7% in women (Seet et. al,
2010) OSA is a prevalent problem in Western Society estimated to occur between 1 to
9% in patients presenting for surgery, yet it is frequently undiagnosed due to lack of
awareness or knowledge of the disorder (Kaw et al, 2006).
OSA is caused by repetitive partial or complete obstruction of the airway during sleep.
Diagnosis of OSA is determined by the occurrence of airway obstruction during sleep
with apnea periods lasting greater than 10 seconds for five or more times per hour; with a
resultant decrease in arterial oxygen saturation (Sa02). (Seet et al, 2010) These events
are known as apnea/hypopnea episodes and the measurement of episodes is referred to as
the Apnea-Hypopnea Index [AHI]. The degree of severity of the disorder is determinate
of the number of AHI per hour. AHI: 5-15 mild, > 15-30 moderate and > 30 severe.
A Polysomnography otherwise known as a Sleep Study is recognized as the "Gold
Standard" for the diagnosis of OSA. Polysomnography data defines the degree of severity
of the condition and number of apneic episodes. Unfortunately polysomnography is time
consuming; patients are reluctant to participate in them; they require an extended stay in
the sleep lab; and they are expensive. Medical professionals have become more aware of
OSA as a significant disorder with resulting adverse effects for their patients. More
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physicians are consulting to sleep labs to ascertain severity and the availability of
appointments have become more limited. Unfortunately for the OSA patient,
polysomnography cannot be obtained rapidly and in the case of surgical interventions that
may be required for urgent or emergent disorders OSA may go undetected. (Chung,
2008) Subsequently, the OSA patient population presents a unique challenge during the
peri-operative period due to an increased risk for lack of identification and subsequent
life threatening complications. Of particular interest to the Nurse Anesthetist, are the
respiratory complications that can result in delayed emergence from anesthesia, delayed
postoperative recovery, increased apneic episodes, hypoxemia, cardiac disturbances and
ultimate death in this patient population.
Literature Review

Obesity, gender, snoring and age have demonstrated to be strong indicators of occurrence
for OSA. Hypertension, cardiovascular disease, diabetes and stroke are prevalently
reported as confounding and coexisting factors (Dykes et al, 1996). In 2003 Netzer at
al, surveyed OSA patients in 26 US primary care clinics and 14 European primary care
clinics comparison of the results demonstrated similar symptoms of age, gender
distribution and hypertension. Obesity was common among both sets of OSA patients
although the incidence was much higher in the United Sates than in Europe. Another
study obtained in Spain by Duran et al, 2001 reported linkages between OSA and
hypertension after interviewing over 2,000 patients.
Elevated blood pressure and refractory bradycardia followed by abrupt tachycardia
are cited as predominate cardiovascular effects of OSA. The hemodynamic instability
seems to be related initially to hypoxemia from the airway obstruction, and then sudden
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arousal as the patient awakens to breath. The rapid fluctuation of vaso-activity is thought
to be responsible for the incidence of cardiac arrhythmias, the development of chronic
arterial hypertension, the occurrence of myocardial infarction and sudden cardiac death.
(Vanninen et al, 1996).

The severity and incidence of documented post surgical complications from patients
with moderate to severe OSA is significant. Yet, most of the informational data of
incidence, occurrence, surgical complications and treatment of the OSA patients come
from case reports and retrospective reviews not evidenced based scientific studies. A
retrospective review in 2008 involved a search of surgical procedures involving patient
who were previously or subsequently diagnosed with OSA. A total of 8,897 articles were
discovered from 1966 to 2007. Limiting of the search to English language, adult
population as well as preferentially selected Level I and II categorized studies: 198
articles were included for analysis whereby the authors clarified further that 18 articles
were level III and IV (lack of adequate blinding, control group or randomization) due to
lack of higher level studies. (Chung et al, 2008)
The American Society of Anesthesiologist (ASA) developed guidelines in 2006, based
on Level IV evidence and expert consensus reports to address the identification and
treatment needs of the OSA patient. The ASA consultants reached agreement on
treatment criteria for most simple outpatient and minor orthopedic surgical procedures
but could not find consensus regarding more invasive surgeries. The guidelines propose
that for more invasive surgery certain factors need to be considered when determining
postoperative risk for the OSA patient these included: status of sleep apnea, (treated or
untreated), level of comorbidities (hypertension, cardiovascular disorders, diabetes are
they appropriately managed), type of surgery, and anesthesia modality. (Chung, 2008)
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The key experts in the diagnosis and treatment of the OSA patient even acknowledge
poor quality of evidence in a citation from the American Academy of Sleep Medicine
stating that the scientific literature regarding perioperative risk and best management
techniques for OSA patients was scanty and of limited quantity. (Meoli et al, 2003)

Purpose and Specific Aims
The purpose of this study is to identify the preexisting factors that significantly affect
postoperative recovery times between patients with Obstructive Sleep Apnea compared to
patients without Obstructive Sleep Apnea undergoing abdominal surgical procedures.
Specific aims to determine the incidence and occurrence of pre existing cofactors:
hypertension, coronary artery disease, and diabetes will be evaluated. Secondary aims
are to determine if relationships of occurrence exist between the co-existing factors. If
relationships of co-existing factors are determined can they be further categorized as
positive or negative relationship?
Methods

An experimental correlational design method will be utilized for determining the
relationship of postoperative ambulatory care unit (PACU) stay times and hypertension
(HTN), diabetes (DM-II), coronary artery disease, and body mass index (BMI) in
obstructive sleep apnea (OSA) patients.
Obstructive Sleep Apnea will be defined utilizing the STOP-BANG screening
parametric, a concise and simple to use screening tool specifically developed to assess
OSA criteria. Stop-Bang is a 12-question tool that has been implemented and validated
for use in defining OSA criteria in a surgical patient population. (Chung, 2008)
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A purposive sample of active duty, retired, or family members of military service
members having consented to elective abdominal surgery at the Naval Medical Center
San Diego (NMCSD) and received a score of 5 or greater from preoperative evaluation
using the STOP-BANG screening measurement. Inclusion Criteria consists of males and
females 18 to 65 years, who have elected to have general anesthesia for abdominal
surgery, category ASA I & II. Exclusion Criteria will consist of members above who
have pre-existing pulmonary disorders (COPD, etc.), neurological dysfunction, delayed
or decreased cognitive function, recent MI. Demographic data will include age, gender,
BMI, medications and type of surgical procedure.
The sample size for this study will be based on the consensus of data establishing a
26% occurrence rate. Utilizing Nunnally and Bernstein (1994) and Katz (2006)
guidelines of ten subjects per predictor, 50 subjects with OSA would be a minimum.
Considering the incidence of OSA in the surgical population of 26% the estimated
sample size for this study is — subjects.
Data Collection Protocol

1. Patients scheduled for elective surgery are directed to the preoperative clinic to
complete a preoperative questionnaire. This questionnaire identifies patients having any
pre-existing disease factors such as hypertension, diabetes, suspected or diagnosed
obstructive sleep apnea. These patients are flagged and required to have a more in depth
assessment by an anesthesia provider prior to their surgery, this could occur anytime
between 1 and 14 days prior to their elected procedure.
2. After informed consent is obtained demographic data will be obtained and Stop Bang
Measurement questionnaire collected and a copy maintained in the patient record for the
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anesthesia providers review on the day of surgery. CPAP use evaluated and instructions
delivered.
3. Data reviewed within the patients' medical record will consist of:
a. Pre-operative Data: The anesthesia pre-operative assessment: (which includes:
medications, NPO status, surgical procedure, review of prior surgeries, review of
systems, allergies, pain assessment, tobacco and alcohol use, lab data: the anesthesia
intraoperative record (innovian computerized electronic record), Essentris PACU
electronic medical report.
b. Intra-Operative Data: Information obtained from electronic anesthesia record
(Innovian) includes all intraoperative anesthetic activity anesthetic agent, pain
medications, muscle relaxants and use or non-use of relaxant reversal medications, anti
emetics and patients vital signs throughout the procedure.
c. Post Operative Data: Aldrete scores, recovery times, respiratory rates, incidence
of desaturations (02 Sat < 90), pulse oximetry measurements, End tidal C02, Cerebral
C02, CPAP use, hypertension documentation and treatment. (Benumof, 2004)

Data analysis plan and procedures.

V. Timeline: (Illustrate a timeline - including the estimated protocol completion and
abstract/manuscript submission dates)
First Article - Manuscript: "Stop Bang Tool use to detect Obstructive Sleep
Apnea for the anesthesia provider." Submission July 2012
Second Article - Manuscript "Obstructive Sleep Apnea: and the effects of
cofactors on PACU Stay Time. Bound and submitted September 2012
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Third Article - AANA Grant Submission due OCT 1st, submission complete by
August 1st 2012.

VI. Budget [List and justify individual items. Be as specific as possible. Equipment
such as computers will not be funded. The AANA Foundation funds up to 15% indirect
costs.]
1. Equipment: Cerebral C02 monitor equipment: 10 Thousand Dollars

Relevance to Nurse Anesthesia

The ultimate goal for all Nurse Anesthetists is to provide the safest, highest quality
anesthetic management and care to their patients. If Nurse Anesthetists can identify and
understand the coexisting factors creating the most risks for perioperative complications
in the OSA defined patient they can better prepare themselves to manage those risks and
provide optimum care. They can select anesthetic practices that minimize risk and
maximize safer outcomes.
Development of more concise and accurate techniques to eliminate the factors
producing increased risk for this population could be incorporated. Valid criteria for
preoperative identification of the OSA patient could be developed and preoperative
management techniques could be identified. Established guidelines and protocols could
be created to eliminate most if not all risk factors. The complete elimination of incidence
and occurrence of morbidity and mortality for the OSA patient in the perioperative
environment would be the ultimate goal
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Implications to Research, Education, Practice, Policy

By better understanding factors that increase the adverse events of OSA, we can better
prepare or even prevent bad outcomes. Identifying characteristics inherently consistent in
patients with OSA will enable anesthesia to alleviate risks, optimize outcomes by
implementing supportive measures and anesthesia techniques that will decrease the
occurrence of hypoxemia, apnea/hypopnea, hypertensive and cardiac events. Once all
mitigating factors are better understood anesthesia providers can direct efforts for
increased study. Optimum anesthetic measures and techniques could be investigated and
incorporated throughout the continuum of perioperative care. Protocols could be
developed as guidelines to provide safer and consistent quality care. Patient can be
advised regarding self-care measures that can enhance their quality of life. Most
important for the anesthesia provider is the further identification of contributing and co
existing factors. The development of accurate and efficient preoperative identification
measure that could prevent adverse events related to OSA could reduce or eliminate lifethreatening outcomes.
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TABLES 1.

Table 1. Pre-Post STOP-BANG & DX OSA

Correlation

OSA DX YES

OSA DX NO

SIGNIFICANCE

PRESTOP
DATA

7.50%

92.50%

NS

POST STOP
DATA

37.60%

62.40%

P< 0.001

COFACTOR
DATA

32.60%

67.40%

P< 0.001

Table 2. OSA vs. Non-OSA & Amount Medications.

COFACTOR

2.07

1.53

1.91

41

MEDICATIONS

1.92

1.13

2.64

40

283.76

235.75

1.76

40

TIME

P<
0.05
P<
0.01
p<
0.05
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TABLES 2.
Table 3. Logistic Regression: Cofactors and Effects on OSA
Variables In the Equation

Step 1"

AirWayProblem

B
1.884

S.E.
.638

Wald
8.714

Sig.

df
1

95% C.l.for
EXP(B)
Upper
Lower
1.884
23.001

Exp(B)

.003

6.582

1.017
1
.054
HTN
.528
3.709
2.766
-.132
1
CAD
.536
.060
.806
.877
-.045
.618
1
.942
Diabetes
.005
.956
GERD
.201
.469
.183
1
.669
1.222
-4.537
1.634
1
Constant
7.708
.005
.011
a. Variable(s) entered on step 1: AirWayProblems, HTN, CAD, Diabetes, GERD.

.982
.307
.284
.488

7.787
2.505
3.212
3.064

Table 4. Linear Regression: Cofactors effect PACU Time.

Unstandardized Coefficients
Model
(Constant)
HTN

Std. Error

Beta

Sig.

t

475.705

140.381

3.389

.001

-202.568

48.910

-.453

-4.142

.000

56.731

47.692

.125

1.190

.237

63.708

56.032

.115

1.137

.258

GERD

-15.944

42.381

-.036

OC
-h
OC
1

Air Way Problems

-27.213

55.520

-.047

a. Dependent Variable: Total PACU Time

1

CAD
Diabetes

CD
O

1

B

Standardized
Coefficients

.708
.625
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LIST OF DIAGRAMS
FIGURE 1. STARLING RESISTOR MODEL

FIGURE 2. OSA SLEEP CYCLE
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